日本臨牀　別冊　呼吸器症候群（第3版）　V

出版社： 日本臨牀社
発行日： 2021-12-31
分野： 臨床医学：一般  >  雑誌
ISSN： 00471852
雑誌名：
特集： 呼吸器症候群（第3版）　V
電子書籍版： 2021-12-31 （第3版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

22,000 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

22,000 円(税込)

購入する

目次

  • 特集　呼吸器症候群（第3版）　V
    　　　―その他の呼吸器疾患を含めて―

    X．腫瘍性疾患　　
    １．上皮性(原発性)腫瘍
    （１）肺癌の病理組織分類
    （２）EGFR遺伝子変異陽性肺癌
    （３）ALK融合遺伝子陽性肺癌（ALK肺癌）
    （４）ROS1融合遺伝子陽性肺癌
    （５）BRAF遺伝子変異陽性肺癌
    （６）NTRK融合遺伝子陽性肺癌
    （７）MET遺伝子を標的とした肺がん治療
    （８）RET融合遺伝子を標的とした肺癌治療
    （９）HER2遺伝子変異陽性肺癌
    （10）KRAS遺伝子変異陽性肺癌
    （11）NRG1融合遺伝子陽性肺癌
    （12）肺扁平上皮癌
    （13）肺・気管支カルチノイド腫瘍
    （14）小細胞肺がん
    （15）大細胞神経内分泌癌
    （16）肉腫様癌
    （17）唾液線型腫瘍
    ２．間葉系(原発性)腫瘍
    （１）肺過誤腫
    （２）炎症性筋線維芽細胞腫
    （３）類上皮性血管内皮腫
    （４）血管肉腫
    （５）滑膜肉腫
    （６）胸部原発粘液線維肉腫
    （７）孤在性線維性腫瘍
    ３．リンパ球系腫瘍
    （１）MALTリンパ腫
    （２）血管内大細胞型B細胞性リンパ腫
    ４．異所性性ホルモン産生腫瘍
    （１）異所性ACTH症候群
    （２）ADH分泌不適合症候群
    ５．その他腫瘍性病変
    （１）Horner症候群
    （２）上大静脈症候群
    （３）Pancoast症候群
    （４）癌性リンパ管症
    （５）肺原発悪性黒色腫
    （６）悪性リンパ腫の肺病変
    （７）白血病の肺病変
    （８）Lambert-Eaton 筋無力症候群

    XI．縦隔疾患　　　
    １．胸腺腫瘍
    （１）Good症候群
    （２）胸腺過形成：真性胸腺過形成と胸腺リンパ濾胞過形成
    （３）胸腺癌
    （４）胸腺奇形腫
    （５）胸腺脂肪腫
    （６）胸腺腫
    （７）胸腺嚢胞・胸腺嚢腫
    （８）浸潤性胸腺腫
    ２．縦隔腫瘍
    （１）Castleman 病
    （２）特発性縦隔気腫（Hamman症候群）
    （３）Solitary fibrous tumor (SFT)
    （４）縦隔未分化多形肉腫（悪性線維性組織球腫）
    （５）縦隔海綿状血管腫
    （６）縦隔気管支性嚢胞
    （７）縦隔奇形腫
    （８）縦隔血管脂肪腫
    （９）縦隔絨毛癌
    （10）縦隔神経原性腫瘍
    （11）縦隔セミノーマ
    （12）縦隔内甲状腺腫
    （13）縦隔内神経鞘腫，神経線維腫
    （14）傍神経節腫
    （15）縦隔肉芽腫
    （16）縦隔嚢胞
    （17）縦隔胚細胞腫瘍
    （18）縦隔(嚢状)ヒグローマ、リンパ管腫
    （19）縦隔副甲状腺嚢腫
    （20）縦隔卵黄嚢腫瘍
    （21）縦隔リンパ腫
    （22）ホジキンリンパ腫
    （23）縦隔リンパ節炎
    （24）神経芽腫
    （25）特発性線維性縦隔炎，硬化性縦隔炎、縦隔線維症
    ３．その他の縦隔疾患
    （１）急性縦隔炎
    （２）縦隔ガス壊疽（降下性壊死性縦隔炎）
    （３）縦隔気腫
    （４）縦隔髄外造血
    （５）縦隔内血腫
    ４．胸壁，胸郭，横隔膜異常，その他疾患
    （１）Boerhaave 症候群(特発性食道破裂)
    （２）Marfan症候群
    （３）Poland症候群
    （４）Straight back症候群
    （５）横隔膜腫瘍
    （６）横隔膜ヘルニア
    （７）横隔膜弛緩症・横隔膜麻痺
    （８）胸部腎
    （９）先天性肺リンパ管拡張症
    （10）漏斗胸
    （11）本邦における胸部外傷の診断・治療の現状

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

X 腫瘍性疾患

P.8 掲載の参考文献
1) WHO Classification of Tumours, 4th ed, Vol 7, WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (ed by Travis WD, et al), IARC, Lyon, 2015.
 
2) Noguchi M, et al : Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75 : 2844-2852, 1995.
 
3) Naito M, et al : Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung. Lung Cancer 100 : 53-62, 2016.
PubMed
4) Motoi N, et al : Lung adenocarcinoma : modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol 32 : 810-827, 2008.
PubMed
5) Ichinokawa H, et al : Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation. Hum Pathol 44 : 2636-2642, 2013.
PubMed
P.12 掲載の参考文献
1) Hynes NE, Lane HA : ERBB receptors and cancer : the complexity of targeted inhibitors. Nat Rev Cancer 5 : 341-354, 2005.
PubMed
2) Lynch TJ, et al : Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 : 2129-2139, 2004.
PubMed
3) 日本肺癌学会バイオマーカー委員会 : 肺癌患者におけるEGFR遺伝子変異検査の手引き 第4.3版 (2020年3月31日), 日本肺癌学会 [https://www.haigan.gr.jp/modules/guideline/index.php?content_id=7] (2021年10月閲覧)
 
4) Mitsudomi T, et al : Biological and clinical implications of EGFR mutations in lung cancer. Int J Clin Oncol 11 : 190-198, 2006.
 
5) Midha A, et al : EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology : a systematic review and global map by ethnicity (mutMap II). Am J Cancer Res 5 : 2892-2911, 2015.
 
6) Shiraishi K, et al : Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma. Nat Commun 7 : 12451, 2016.
PubMed
7) Maemondo M, et al : Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362 : 2380-2388, 2010.
 
8) Mitsudomi T, et al : Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405) : an open label, randomised phase 3 trial. Lancet Oncol 11 : 121-128, 2010.
PubMed
9) Kobayashi S, et al : EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 352 : 786-792, 2005.
PubMed
10) Mok TS, et al : Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer. N Engl J Med 376 : 629-640, 2017.
 
11) Soria JC, et al : Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer. N Engl J Med 378 : 113-125, 2018.
PubMed
12) Ramalingam SS, et al : Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC. N Engl J Med 382 : 41-50, 2020.
PubMed
13) Ramalingam SS, et al : Mechanisms of acquired resistance to first-line osimertinib : preliminary data from the phase III FLAURA study [abstract LBA50]. Ann Oncol 29 (Suppl 8) : viii740, 2018.
 
14) Marcoux N, et al : EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas : Clinical Outcomes. J Clin Oncol 37 : 278-285, 2019.
PubMed
15) Hosomi Y, et al : Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor : NEJ009 Study. J Clin Oncol 38 : 115-123, 2020.
PubMed
16) Saito H, et al : Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026) : interim analysis of an open-label, randomised, multicentre, phase 3 trial. Lancet Oncol 20 : 625-635, 2019.
PubMed
17) Nakagawa K, et al : Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY) : a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 20 : 1655-1669, 2019.
PubMed
18) 肺癌診療ガイドライン-悪性胸膜中皮腫・胸腺腫瘍含む- [2020年版] (日本肺癌学会編), 金原出版, 2021.
 
19) Oizumi S, et al : Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer : quality of life analysis of North East Japan Study Group 002 Trial. Oncologist 17 : 863-870, 2012.
 
20) Okamoto I, et al : Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer : Long-term follow-up of a large patient cohort. Lung Cancer 117 : 14-19, 2018.
PubMed
P.17 掲載の参考文献
1) Mano H : ALKoma : a cancer subtype with a shared target. Cancer Discov 2 : 495-502, 2012.
PubMed
2) Gainor JF, et al : Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer. Cancer Discov 6 : 1118-1133, 2016.
PubMed
3) 肺癌患者におけるALK融合遺伝子検査の手引き [第3.1版] (日本肺癌学会バイオマーカー委員会編), 日本肺癌学会, 2019.
 
P.20 掲載の参考文献
1) Charest A, et al : Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del (6) (q21q21). Genes Chromosomes Cancer 37 : 58-71, 2003.
 
2) Rikova K, et al : Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131 : 1190-1203, 2007.
PubMed
3) Shaw AT, et al : Tyrosine kinase gene rearrangements in epithelial malignancies. Nat Rev Cancer 13 : 772-787, 2013.
PubMed
4) Bergethon K, et al : ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 30 : 863-870, 2012.
PubMed
5) Parikh DA, et al : Characteristics of Patients With ROS1+ Cancers : Results From the First Patient-Designed, Global, Pan-Cancer ROSI Data Repository. JCO Oncol Pract 16 : e183-e189, 2020.
 
6) Lin JJ, et al : ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non-Small Cell Lung Cancer. J Thorac Oncol 12 : 872-877, 2017.
PubMed
7) Gainor JF, et al : Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non-Small-Cell Lung Cancer. JCO Precis Oncol 2017 : PO.17.0006.3, 2017.
 
8) Chiari R, et al : ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism : Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS). Clin Lung Cancer 21 : 15-20, 2020.
PubMed
9) Alexander M, et al : A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer. Lung Cancer 142 : 34-40, 2020.
 
10) Wahrenbrock M, et al : Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 112 : 853-862, 2003.
PubMed
11) Shaw AT, et al : Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med 371 : 1963-1971, 2014.
PubMed
12) Shaw AT, et al : Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC) : updated results, including overall survival, from PROFILE 1001. Ann Oncol 30 : 1121-1126, 2019.
PubMed
13) Wu YL, et al : Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer. J Clin Oncol 36 : 1405-1411, 2018.
PubMed
14) Dziadziuszko R, et al : Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. J Clin Oncol 39 : 1253-1263, 2021.
 
15) Lim SM, et al : Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement. J Clin Oncol 35 : 2613-2618, 2017.
PubMed
16) Shaw AT, et al : Lorlatinib in advanced ROS1-positive non-small-cell lung cancer : a multicentre, open-label, single-arm, phase 1-2 trial. Lancet Oncol 20 : 1691-1701, 2019.
PubMed
17) Scagliotti GV, et al : Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26 : 3543-3551, 2008.
PubMed
18) Paz-Ares LG, et al : PARAMOUNT : Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. J Clin Oncol 31 : 2895-2902, 2013.
PubMed
19) Chen YF, et al : Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations. J Thorac Oncol 11 : 1140-1152, 2016.
PubMed
20) Mazieres J, et al : Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations : results from the IMMUNOTARGET registry. Ann Oncol 30 : 1321-1328, 2019.
PubMed
P.25 掲載の参考文献
1) Davies H, et al : Mutations of the BRAF gene in human cancer. Nature 417 : 949-954, 2002.
PubMed
2) Kris MG, et al : Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA 311 : 1998-2006, 2014.
PubMed
3) Villaruz LC, et al : Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Cancer 121 : 448-456, 2015.
PubMed
4) Marchetti A, et al : Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. J Clin Oncol 29 : 3574-3579, 2011.
PubMed
5) Zheng D, et al : Prevalence and Clinicopathological Characteristics of BRAF Mutations in Chinese Patients with Lung Adenocarcinoma. Ann Surg Oncol 22 (Suppl 3) : S1284-1291, 2015.
 
6) Paik PK, et al : Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. J Clin Oncol 29 : 2046-2051, 2011.
PubMed
7) Yang H, et al : RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models. Cancer Res 70 : 5518-5527, 2010.
PubMed
8) Planchard D, et al : Dabrafenib in patients with BRAF (V600E) -positive advanced non-small-cell lung cancer : a single-arm, multicentre, open-label, phase 2 trial. Lancet Oncol 17 : 642-650, 2016.
PubMed
9) Hyman DM, et al : Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations. N Engl J Med 373 : 726-736, 2015.
PubMed
10) Subbiah V, et al : Efficacy of Vemurafenib in Patients With Non-Small-Cell Lung Cancer With BRAF V600 Mutation : An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET Study. JCO Precis Oncol 3 : PO.18.00266, 2019.
 
11) Su F, et al : RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. N Engl J Med 366 : 207-215, 2012.
PubMed
12) Long GV, et al : Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. N Engl J Med 371 : 1877-1888, 2014.
PubMed
13) Planchard D, et al : Dabrafenib plus trametinib in patients with previously treated BRAF (V600E) -mutant metastatic non-small cell lung cancer : an open-label, multicentre phase 2 trial. Lancet Oncol 17 : 984-993, 2016.
PubMed
14) Planchard D, et al : Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer : an open-label, phase 2 trial. Lancet Oncol 18 : 1307-1316, 2017.
PubMed
P.30 掲載の参考文献
1) Barbacid M, et al : The trk family of tyrosine protein kinase receptors. Biochim Biophys Acta 1072 : 115-127, 1991.
PubMed
2) Pulciani S, et al : Oncogenes in solid human tumours. Nature 300 : 539-542, 1982.
PubMed
3) Martin-Zanca D, et al : A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319 : 743-748, 1986.
PubMed
4) Vaishnavi A, et al : Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nat Med 19 : 1469-1472, 2013.
 
5) Cocco E, et al : NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol 15 : 731-747, 2018.
PubMed
6) Marchetti A, et al : Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung. Hum Mutat 29 : 609-616, 2008.
PubMed
7) Okamura R, et al : Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies : Implications for NTRK-Targeted Therapeutics. JCO Precis Oncol 2 : PO.18.00183, 2018.
 
8) Farago AF, et al : Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring an NTRK Gene Fusion. JCO Precis Oncol 2 : PO.18.00037, 2018.
 
9) Lin JJ, et al : Long-term efficacy and safety of larotrectinib in patients with TRK fusion-positive lung cancer. J Clin Oncol 39 (15 Suppl) : abstract 9109, 2021.
 
10) Solomon JP, Hechtman JF : Detection of NTRK Fusions : Merits and Limitations of Current Diagnostic Platforms. Cancer Res 79 : 3163-3168, 2019.
PubMed
11) Drilon A : TRK inhibitors in TRK fusion-positive cancers. Ann Oncol 30 (Suppl 8) : viii23-viii30, 2019.
 
12) Doebele RC, et al : Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours : integrated analysis of three phase 1-2 trials. Lancet Oncol 21 : 271-282, 2020.
 
13) Hong DS, et al : Larotrectinib in patients with TRK fusion-positive solid tumours : a pooled analysis of three phase 1/2 clinical trials. Lancet Oncol 21 : 531-540, 2020.
PubMed
14) Paz-Ares L, et al : Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC) : integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001. Ann Oncol 30 (Suppl 2) : ii48-ii49, 2019.
 
15) Liu D, et al : Characterization of on-target adverse events caused by TRK inhibitor therapy. Ann Oncol 31 : 1207-1215, 2020.
 
P.35 掲載の参考文献
1) Liang H, Wang M : MET Oncogene in Non-Small Cell Lung Cancer : Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis. Onco Targets Ther 13 : 2491-2510, 2020.
PubMed
2) Cancer Genome Atlas Research Network : Comprehensive genomic characterization of squamous cell lung cancers. Nature 489 : 519-525, 2012.
 
3) Cancer Genome Atlas Research Network : Comprehensive molecular profiling of lung adenocarcinoma. Nature 511 : 543-550, 2014.
 
4) Spigel DR, et al : Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer : METLung. J Clin Oncol 35 : 412-420, 2017.
PubMed
5) Engelman JA, et al : MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316 : 1039-1043, 2007.
PubMed
6) Scagliotti G, et al : A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation-Positive NSCLC Patients. J Thorac Oncol 15 : 80-90, 2020.
PubMed
7) Kong-Beltran M, et al : Somatic mutations lead to an oncogenic deletion of met in lung cancer. Cancer Res 66 : 283-289, 2006.
 
8) Schildhaus HU, et al : MET amplification status in therapy-naive adeno-and squamous cell carcinomas of the lung. Clin Cancer Res 21 : 907-915, 2015.
PubMed
9) Drilon A : MET Exon 14 Alterations in Lung Cancer : Exon Skipping Extends Half-Life. Clin Cancer Res 22 : 2832-2834, 2016.
PubMed
10) Awad MM, et al : MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression. J Clin Oncol 34 : 721-730, 2016.
 
11) Liu X, et al : Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations. J Clin Oncol 34 : 794-802, 2016.
PubMed
12) Paik PK, et al : Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations. N Engl J Med 383 : 931-943, 2020.
PubMed
13) 日本肺癌学会バイオマーカー委員会 : 肺癌患者におけるMETex14 skipping検査の手引き [第1.0版], 2020. 9. 15.
 
14) 添付文書, ArcherMETコンパニオン診断システム [第1版], 2020. 4.
 
15) Wolf J, et al : Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer. N Engl J Med 383 : 944-957, 2020.
 
P.38 掲載の参考文献
1) Kohno T, et al : KIF5B-RET fusions in lung adenocarcinoma. Nat Med 18 : 375-377, 2012.
PubMed
2) Tan AC, et al : Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC. J Thorac Oncol 15 : 1928-1934, 2020.
PubMed
3) Tsuta K, et al : RET-rearranged non-small-cell lung carcinoma : a clinicopathological and molecular analysis. Br J Cancer 110 : 1571-1578, 2014.
PubMed
4) Pan Y, et al : ALK, ROSI and RET fusions in 1139 lung adenocarcinomas : a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features. Lung Cancer 84 : 121-126, 2014.
 
5) Yoh K, et al : Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell iung cancer (LURET) : an open-label, multicentre phase 2 trial. Lancet Respir Med 5 : 42-50, 2017.
 
6) Drilon A, et al : Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer : an open-label, single-centre, phase 2, single-arm trial, Lancet Oncol 17 : 1653-1660, 2016.
PubMed
7) Hida T, et al : A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma. Lung Cancer 138 : 124-130, 2019.
PubMed
8) Drilon A, et al : Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer. N Engl J Med 383 : 813-824, 2020.
PubMed
9) Subbiah V, et al : Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial. Clin Cancer Res 27 : 4160-4167, 2021.
PubMed
10) Gainor JF, et al : Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW) : a multi-cohort, open-label, phase 1/2 study. Lancet Oncol 22 : 959-969, 2021.
 
11) Solomon BJ, et al : RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies. J Thorac Oncol 15 : 541-549, 2020.
PubMed
12) Lin JJ, et al : Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer. Ann Oncol 31 : 1725-1733, 2020,
PubMed
13) Rosen EY, et al : Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib. Clin Cancer Res 27 : 34-42, 2021.
PubMed
P.45 掲載の参考文献
1) Ninomiya K, et al : A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY). Chest 156 : 357-366, 2019.
PubMed
2) Shigematsu H, et al : Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Res 65 : 1642-1646, 2005.
PubMed
3) Arcila ME, et al : Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas. Clin Cancer Res 18 : 4910-4918, 2012.
PubMed
4) Robichaux JP, et al : Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DMI Activity. Cancer Cell 37 : 420, 2020.
PubMed
5) Kosaka T, et al : Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors. Cancer Res 77 : 2712-2721, 2017.
PubMed
6) Kris MG, et al : Targeting HER2 aberrations as actionable drivers in lung cancers : phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors. Ann Oncol 26 : 1421-1427, 2015.
PubMed
7) Mazieres J, et al : Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs : results from the European EUHER2 cohort. Ann Oncol 27 : 281-286, 2016.
PubMed
8) Peters S, et al : Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation-Positive Advanced NSCLC : Findings From a Global Named Patient Use Program. J Thorac Oncol 13 : 1897-1905, 2018.
 
9) Li BT, et al : HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Arnplified or Mutant Lung Cancers. Cancer Discov 10 : 674-687, 2020.
PubMed
10) Gatzemeier U, et al : Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer. Ann Oncol 15 : 19-27, 2004.
 
11) Hotta K, et al : A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non-Small Cell Lung Cancer. J Thorac Oncol 13 : 273-279, 2018.
PubMed
12) Peters S, et al : Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer : Efficacy, Safety, and Biomarkers. Clin Cancer Res 25 : 64-72, 2019.
PubMed
13) Socinski MA, et al : ZENITH20, a multinational, multi-cohort phase II study of poziotinib in NSCLC patients with EGFR or HER2 exon 20 insertion mutations [abstract LBA60]. Ann Oncol 31 (Suppl 4) : S1142-S1215, 2020.
 
14) Li BT, et al : Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers : Results From a Phase II Basket Trial. J Clin Oncol 36 : 2532-2537, 2018.
 
15) Smit EF, et al : Trastuzumab deruxtecan (T-DXd ; DS-8201) in patients with HER2-mutated metastatic non-small cell lung cancer (NSCLC) : Interim results of DESTINY-Lung01. J Clin Oncol 38 (15 Suppl) : abstract 9504, 2020.
 
P.50 掲載の参考文献
1) Reck M, et al : Targeting KRAS in non-small-cell lung cancer : recent progress and new approaches. Ann Oncol 32 : 1101-1110, 2021.
PubMed
2) Indini A, et al : Targeting KRAS in Solid Tumors : Current Challenges and Future Opportunities of Novel KRAS Inhibitors. Pharmaceutics 13 : 653, 2021.
PubMed
3) Ostrem JM, et al : K-Ras (G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 503 : 548-551, 2013.
PubMed
4) Skoulidis F, et al : Sotorasib for Lung Cancers with KRAS p.G12C Mutation. N Engl J Med 384 : 2371-2381, 2021.
 
5) Yang H, et al : New Horizons in KRAS-Mutant Lung Cancer : Dawn After Darkness. Front Oncol 9 : 953, 2019.
PubMed
6) Yu HA, et al : Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas. J Thorac Oncol 10 : 431-437, 2015.
PubMed
7) Shepherd FA, et al : Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy. J Clin Oncol 31 : 2173-2181, 2013.
PubMed
8) Mazieres J, et al : Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations : results from the IMMUNOTARGET registry. Ann Oncol 30 : 1321-1328, 2019.
PubMed
9) Landre T, et al : Anti-PD- (L) 1 for KRAS-mutant advanced non-small-cell lung cancers : a meta-analysis of randomized-controlled trials. Cancer Immunol Immunother, 2021. (DOI : 10.1007/s00262-021-03031-1)
 
10) Arbour KC, et al : Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer. 2021 ASCO Annual Meeting, #9088, Chicago, 2021. 6.
 
11) Canon J, et al : The clinical KRAS (G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature 575 : 217-223, 2019.
PubMed
12) Hong DS, et al : KRASGI2C Inhibition with Sotorasib in Advanced Solid Tumors. N Engl J Med 383 : 1207-1217, 2020.
PubMed
13) Awad MM, et al : Acquired Resistance to KRASG12C Inhibition in Cancer. N Engl J Med 384 : 2382-2393, 2021.
PubMed
P.55 掲載の参考文献
1) Montero JC, et al : Neuregulins and cancer. Clin Cancer Res 14 : 3237-3241, 2008.
PubMed
2) Wilson TR, et al : Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers. Cancer Cell 20 : 158-172, 2011.
 
3) Gay ND, et al : Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions. J Thorac Oncol 12 : e107-e110, 2017.
PubMed
4) Shin DH, et al : Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung. Oncotarget 7 : 69450-69465, 2016.
PubMed
5) Fernandez-Cuesta L, et al : CD74-NRG1 fusions in lung adenocarcinoma. Cancer Discov 4 : 415-422, 2014.
PubMed
6) Drilon A, et al : Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers. Cancer Discov 8 : 686-695, 2018.
PubMed
7) Jonna S, et al : Detection of NRG1 Gene Fusions in Solid Tumors. Clin Cancer Res 25 : 4966-4972, 2019.
PubMed
8) Laskin J, et al : NRGI fusion-driven tumors : biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. Ann Oncol 31 : 1693-1703, 2020.
 
9) Dhanasekaran SM, et al : Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes. Nat Commun 5 : 5893, 2014.
PubMed
10) Schram A, et al : Efficacy and safety of zenocutuzumab in advanced pancreas cancer and other solid tumors harboring NRG1 fusions. J Clin Oncol 39 (Suppl 15) : abstract 3003, 2021.
 
11) Goto Y, et al : NRG1-fusion-driven solid tumours : A case series indicating the therapeutic potential of afatinib. Ann Oncol 30 (Suppl 9) : ix22-29, 2019.
 
12) Duruisseaux M, et al : NRG1 fusion positive lung cancers : clinicopathologic profile and treatment outcomes from a global multicenter registry. J Clin Oncol 37 (Suppl 15) : abstract 9081, 2019.
 
P.60 掲載の参考文献
1) 臨床・病理 肺癌取扱い規約 [第8版] (日本肺癌学会編), 金原出版, 2017.
 
2) 肺癌診療ガイドライン-悪性胸膜中皮腫・胸腺腫瘍含む- [2020年版] (日本肺癌学会編), 金原出版, 2021.
 
3) Martin-Ucar AE, et al : A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg 27 : 675-679, 2005.
 
4) Matsuo Y, et al : Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy : A propensity score matching analysis. Eur J Cancer 50 : 2932-2938, 2014.
 
5) Pritchard RS, Anthony SP : Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis. Ann Intern Med 125 : 723-729, 1996.
PubMed
6) Antonia SJ, et al : Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC. N Engl J Med 379 : 2342-2350, 2018.
PubMed
7) Pignon JP, et al : Lung adjuvant cisplatin evaluation : a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26 : 3552-3559, 2008.
 
8) Hamada C, et al : Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. J Clin Oncol 23 : 4999-5006, 2005.
PubMed
9) Reck M, et al : Updated Analysis of KEYNOTE-024 : Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. J Clin Oncol 37 : 537-546, 2019.
PubMed
10) Herbst RS, et al : Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC. N Engl J Med 383 : 1328-1339, 2020.
PubMed
11) Hellmann MD, et al : Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. N Engl J Med 381 : 2020-2031, 2019.
PubMed
12) Paz-Ares L, et al : Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer. N Engl J Med 379 : 2040-2051, 2018.
PubMed
13) Paz-Ares L, et al : First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA) : an international, randomised, open-label, phase 3 trial. Lancet Oncol 22 : 198-211, 2021.
PubMed
14) Thatcher N, et al : Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE) : an open-label, randomised, controlled phase 3 trial. Lancet Oncol 16 : 763-774, 2015.
PubMed
15) Garon EB, et al : Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL) : a multicentre, double-blind, randomised phase 3 trial. Lancet 384 : 665-673, 2014.
 
P.65 掲載の参考文献
1) Beasley MB, et al : Carcinoid tumour. In : WHO Classification of Tumours, 4th ed, Vol 7, WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (ed by Travis WD, et al), p73-77, IARC Press, Lyon, 2015.
 
2) WHO Classification of Tumours, 4th ed, Vol 3, WHO Classification of Tumours of the Digestive System (ed by Bosman FT, et al), IARC Press, Lyon, 2010.
 
3) Papotti M, et al : Carcinoid/neuroendocrine tumour of the lung. In : WHO Classification of Tumours, 5th ed, Vol 5, Thoracic Tumours (ed by WHO Classification of Tumours Editorial Board), p133-138, IARC Press, Lyon, 2021.
 
4) Baudin E, et al : Lung and thymic carcinoids : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Ann Oncol 32 : 439-451, 2021.
 
5) Walters SL, et al : A national study of surgically-managed atypical pulmonary carcinoid tumors. Ann Thorac Surg, 112 : 921-927, 2021.
PubMed
6) Dasari A, et al : Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol 3 : 1335-1342, 2017.
PubMed
7) Caplin ME, et al : Pulmonary neuroendocrine (carcinoid) tumors : European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol 26 : 1604-1620, 2015.
PubMed
8) 楠本昌彦 : まれな肺腫瘍の画像診断. 肺癌 55 : 1037-1044, 2015.
Medical*Online
9) 元井紀子, 石川雄一 : カルチノイド腫瘍. 腫瘍病理鑑別診断アトラス 肺癌 (深山正久, ほか編), p119-132, 文光堂, 2014.
 
10) Asamura H, et al : Neuroendocrine neoplasms of the lung : a prognostic spectrum. J Clin Oncol 24 : 70-76, 2006.
 
11) Pavel M, et al : ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site. Neuroendocrinology 103 : 172-185, 2016.
PubMed
12) Wolin EM : Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung. Chest 151 : 1141-1146, 2017.
PubMed
13) Yao JC, et al : Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4) : a randomised, placebo-controlled, phase 3 study. Lancet 387 : 968-977, 2016.
 
14) Fazio N, et al : Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors : RADIANT-4 lung subgroup analysis. Cancer Sci 109 : 174-181, 2018.
PubMed
15) Strosberg J, et al : Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. N Engl J Med 376 : 125-135, 2017.
PubMed
P.70 掲載の参考文献
1) Tsuchiya R, et al : Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer : the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg 129 : 977-983, 2005.
 
2) Pignon JP, et al : A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327 : 1618-1624, 1992.
PubMed
3) Takada M, et al : Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer : results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20 : 3054-3060, 2002.
 
4) Turrisi AT 3rd, et al : Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340 : 265-271, 1999.
PubMed
5) Faivre-Finn C, et al : Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial. Lancet Oncol 18 : 1116-1125, 2017.
PubMed
6) Noda K, et al : Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346 : 85-91, 2002.
PubMed
7) Okamoto H, et al : Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer : JCOG 9702. Br J Cancer 97 : 162-169, 2007.
PubMed
8) Horn L, et al : First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med 379 : 2220-2229, 2018.
PubMed
9) Paz-Ares L, et al : Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) : a randomised, controlled, open-label, phase 3 trial. Lancet 394 : 1929-1939, 2019.
PubMed
10) Von Pawel J, et al : Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small cell lung cancer. J Clin Oncol 32 : 4012-4019, 2014.
PubMed
11) Auperin A, et al : Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341 : 476-484, 1999.
 
12) Takahashi T, et al : Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer : a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 18 : 663-671, 2017.
 
P.76 掲載の参考文献
1) Rekhtman N, et al : Large cell neuroendocrine carcinoma of the lung. In : WHO Classification of Tumours, 5th ed, Vol 5, Thoracic Tumours (ed by WHO Classification of Tumours Editorial Board), p144-149, International Agency for Research on Cancer, Lyon, 2021.
 
2) 谷田部恭, 野口雅之 : 臨床・病理 肺癌取扱い規約 [第8版補訂版] (日本肺癌学会編), p98-102, 金原出版, 2021.
 
3) Takei H, et al : Large cell neuroendocrine carcinoma of the lung : a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 124 : 285-292, 2002.
 
4) Derks JL, et al : Clinical features of large cell neuroendocrine carcinoma : a population-based overview. Eur Respir J 47 : 615-624, 2016.
PubMed
5) Travis WD : Advances in neuroendocrine lung tumors. Ann Oncol 21 (Suppl 7) : vii65-71, 2010.
 
6) Naidoo J, et al : Large Cell Neuroendocrine Carcinoma of the Lung : Clinico-Pathologic Features, Treatment, and Outcomes. Clin Lung Cancer 17 : e121-e129, 2016.
PubMed
7) George J, et al : Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nat Commun 9 : 1048, 2018.
PubMed
8) Oshiro Y, et al : CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients. AJR Am J Roentgenol 182 : 87-91, 2004.
PubMed
9) Derks JL, et al : Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens? Histopathology 74 : 555-566, 2019.
PubMed
10) Gu J, et al : The demographic and treatment options for patients with large cell neuroendocrine carcinoma of the lung. Cancer Med 8 : 2979-2993, 2019.
PubMed
11) Cao L, et al : Clinicopathological characteristics, treatment and survival of pulmonary large cell neuroendocrine carcinoma : a SEER population-based study. PeerJ 7 : e6539, 2019.
PubMed
12) Rossi G, et al : Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRα, PDGFRβ, and Met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol 23 : 8774-8785, 2005.
 
13) Iyoda A, et al : Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. Ann Thorac Surg 82 : 1802-1807, 2006.
PubMed
14) Kenmotsu H, et al : Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung : JCOG1205/1206. J Clin Oncol 38 : 4292-4301, 2020.
PubMed
15) Limonnik V, et al : Factors associated with treatment receipt and overall survival for patients with locally advanced large cell neuroendocrine carcinoma of the lung : A National Cancer Database analysis. Lung Cancer 150 : 107-113, 2020.
 
16) Sun JM, et al : Chemotherapy for pulmonary large cell neuroendocrine carcinoma : similar to that for small cell lung cancer or non-small cell lung cancer? Lung Cancer 77 : 365-370, 2012.
PubMed
17) Le Treut J, et al : Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma : the GFPC 0302 study. Ann Oncol 24 : 1548-1552, 2013.
PubMed
18) Niho S, et al : Combination chemotherapy with irinotecan and cisplatin for large-cell neuroendocrine carcinoma of the lung : a multicenter phase II study. J Thorac Oncol 8 : 980-984, 2013.
 
19) Derks JL, et al : Chemotherapy for pulmonary large cell neuroendocrine carcinomas : does the regimen matter? Eur Respir J 49 : 1601838, 2017.
PubMed
20) Derks JL, et al : Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome. Clin Cancer Res 24 : 33-42, 2018.
PubMed
21) Dudnik E, et al : Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung. J Immunother Cancer 9 : e001999, 2021.
 
P.81 掲載の参考文献
1) 臨床・病理 肺癌取扱い規約 [第8版] (日本肺癌学会編), 金原出版, 2017.
 
2) WHO Classification of Tumours, 5th ed, Vol 5, Thoracic Tumours (ed by WHO Classification of Tumours Editorial Board), IARC, Lyon, 2021.
 
P.86 掲載の参考文献
1) Falk N, et al : Primary Pulmonary Salivary Gland-type Tumors : A Review and Update. Adv Anat Pathol 23 : 13-23, 2016.
PubMed
2) Ishikawa Y, et al : Salivary gland-type tumours. In : WHO Classification of Tumours, 4th ed, Vol 7, WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (ed by Travis WD, et al), p99-105, IARC Press, Lyon, 2015.
 
3) Lokuhetty D, et al : Thoracic Tumours. In : WHO Classification of Tumours, 5th ed, Vol 5, Thoracic Tumours (ed by WHO Classification of Tumours Editorial Board), p115-126, IARC Press, Lyon, 2021.
 
4) Travis WD, et al : Tumors of Salivary Gland Type. In : AFIP Atlas of Tumor Pathology, Series 4, Fascicle 29 : Tumors of the Lower Respiratory Tract, p339-370, American Registry of Pathology, Washington DC, 2019.
 
5) Resio BJ, et al : Primary Salivary Type Lung Cancers in the National Cancer Database. Ann Thorac Surg 105 : 1633-1639, 2018.
PubMed
6) Salem A, et al : Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma : the MD Anderson Cancer Center experience and comprehensive review of the literature. Virchows Arch 470 : 619-626, 2017.
 
7) Komiya T, et al : Primary lung mucoepidermoid carcinoma : analysis of prognostic factors using surveillance, epidemiology and end results program. Clin Respir J 11 : 847-853, 2017.
PubMed
8) Kurnar V, et al : A Comparative Study of Primary Adenoid Cystic and Mucoepidermoid Carcinoma of Lung. Front Oncol 8 : 153, 2018.
 
9) Nakashima Y, et al : Epithelial-myoepithelial carcinoma of the lung : a case report. Surg Case Rep 4 : 74, 2018.
 
10) Elnayal A, et al : Primary salivary gland-type lung cancer : imaging and clinical predictors of outcome. AJR Am J Roentgenol 201 : W57-63, 2013.
PubMed
11) 楠本昌彦 : まれな肺腫瘍の画像診断. 肺癌 55 : 1037-1044, 2015.
Medical*Online
P.89 掲載の参考文献
1) Albrecht E : Ueber Hamartome. Verh Dtsch Ges Pathol 7 : 153-157, 1904.
 
2) Ober WB : Selected items from the history of pathology : Eugen Albrecht, MD (1872-1908) : hamartoma and choristoma. Am J Pathol 91 : 606, 1978.
 
3) Carlsen CJ, et al : Chondromatous hamartoma of the lung. Thorax 5 : 283-292, 1950.
PubMed
4) Travis WD, et al : The 2015 World Health Organization Classification of Lung Tumors : Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol 10 : 1243-1260, 2015.
PubMed
5) Arrigoni MG, et al : Benign tumors of the lung. A ten-year surgical experience. J Thorac Cardiovasc Surg 60 : 589-599, 1970.
 
6) Khouri NF, et al : The solitary pulmonary nodule. Assessment, diagnosis, and management. Chest 91 : 128-133, 1987.
PubMed
7) Gjevre JA, et al : Pulmonary hamartomas. Mayo Clin Proc 71 : 14-20, 1996.
PubMed
8) Guo W, et al : Surgical treatment and outcome of pulmonary hamartoma : a retrospective study of 20-year experience. J Exp Clin Cancer Res 27 : 8, 2008.
PubMed
9) van den Bosch JM, et al : Mesenchymoma of the lung (so called hamartoma) : a review of 154 parenchymal and endobronchial cases. Thorax 42 : 790-793, 1987.
PubMed
10) 塩沢正俊, ほか : 肺過誤腫の臨床と病理-調査票方式による検討から-1. 臨床像について. 日本胸部臨床 28 : 45-56, 1969.
 
11) 小橋吉博, ほか : 閉塞性肺炎を契機に経気管支生検で診断した気管支内過誤腫の1例. 気管支学 25 : 344-348, 2003.
Medical*Online
12) Fletcher JA, et al : Lineage-restricted clonality in biphasic solid tumors. Am J Pathol 138 : 1199-1207, 1991.
PubMed
13) Kazmierczak B, et al : Ahigh frequency of tumors with rearrangements of genes of the HMGI (Y) family in a series of 191 pulmonary chondroid hamartomas. Genes Chromosomes Cancer 26 : 125-133, 1999.
 
14) 吉田朗彦 : 肺の過誤腫. 呼吸 29 : 275-280, 2010.
Medical*Online
15) Hansen CP, et al : Pulmonary hamartoma. J Thorac Cardiovasc Surg 104 : 674-678, 1992.
PubMed
16) Nathan MH, et al : Differentiation of benign and malignant pulmonary nodules by growth rate. Radiology 79 : 221-232, 1962.
PubMed
17) 徳永俊照, ほか : 外科的切除により診断された肺過誤腫の臨床像の検討. 日本呼吸器外科学会雑誌 22 : 746-752, 2008.
 
18) 中谷貴美子, ほか : 気管・気管支内過誤腫. 呼吸 29 : 726-729, 2010.
Medical*Online
19) 窪田幸司, ほか : 肺実質への進展が確認された気管支内腔型肺過誤腫の1例. 気管支学 42 : 524-528, 2020.
Medical*Online
20) Khan AN, et al : The calcified lung nodule : What does it mean? Ann Thorac Med 5 : 67-79, 2010.
PubMed
21) Siegelman SS, et al : Pulmonary hamartoma : CT findings. Radiology 160 : 313-317, 1986.
PubMed
22) Himpe U, et al : Unexpected slight fluorodeoxyglucose-uptake on positron emission tomography in a pulmonary hamartoma. J Thorac Oncol 4 : 107-108, 2009.
 
23) 湯浅幸吉, ほか : 気管支内過誤腫の2治験例-本邦報告62例についての臨床的検討. 日本呼吸器外科学会雑誌 6 : 166-174, 1992.
 
24) Abdel Hady SM, et al : Is surgical resection superior to bronchoscopic resection in patients with symptomatic endobronchial hamartoma? Interact Cardiovasc Thorac Surg 24 : 778-782, 2017.
PubMed
25) 近藤展行, ほか : 巨大な気管支内過誤腫に対して高周波スネアを用いて気管支鏡下切除を行った1例. 気管支学 38 : 390-394, 2016.
Medical*Online
P.94 掲載の参考文献
1) Casanova M, et al : Inflammatory myofibroblastic tumor : The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG). Eur J Cancer 127 : 123-129, 2020.
 
2) Cerfolio RJ, et al : Inflammatory pseudotumors of the lung. Ann Thorac Surg 67 : 933-936, 1999.
PubMed
3) Mahajan P, et al : Inflammatory myofibroblastic tumor : molecular landscape, targeted therapeutics, and remaining challenges. Curr Probl Cancer 45 : 100768 : 2021.
PubMed
4) Ma Z, et al : Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 37 : 98-105, 2003.
 
5) Yamamoto H, et al : ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Histopathology 69 : 72-83, 2016.
PubMed
6) Chang JC, et al : Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements. J Thorac Oncol 14 : 825-834, 2019.
PubMed
7) Fukano R, et al : Time lag between the increase of IL-6 with fever and NF-κB activation in the peripheral blood in inflammatory myofibroblastic tumor. Cytokine 44 : 293-297, 2008.
 
8) Debonis SA, et al : ALK-negative lung inflammatory myofibroblastic tumor in a young adult : A case report and literature review of molecular alterations. Medicine (Baltimore) 100 : e25972, 2021.
 
9) Taylor MS, et al : Morphologic Overlap Between Inflammatory Myofibroblastic Tumor and IgG4-related Disease : Lessons From Next-generation Sequencing. Am J Surg Pathol 43 : 314-324, 2019.
PubMed
10) 寺下智美, ほか : 経気管支針生検にて術前診断しえた炎症性筋線維芽細胞腫の1例. 気管支学 40 : 163-167, 2018.
Medical*Online
11) Grunholz D, et al : Peritoneal myofibroblastic tumor successfully treated with infliximab : Report of one case. Rev Med Chil 143 : 943-947, 2015.
PubMed
12) Butrynski JE, et al : Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 363 : 1727-1733, 2010.
PubMed
13) Mansfield AS, et al : Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib. Ann Oncol 27 : 2111-2117, 2016.
 
14) Saiki M, et al : Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene. Jpn J Clin Oncol 47 : 1189-1192, 2017.
PubMed
15) Xu X, et al : ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib : A case report. Oncol Lett 17 : 2370-2376, 2019.
PubMed
P.97 掲載の参考文献
1) Dail D, Liebow A : Intravascular bronchioloalveolar tumor [abstract]. Am J Pathol 78 : 6a-7a, 1975.
 
2) Weiss SW, Enzinger FM : Epithelioid hemangioendothelioma : a vascular tumor often mistaken for a carcinoma. Cancer 50 : 970-981, 1982.
PubMed
3) De Pinieux G, et al : Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network. PLoS One 16 : e0246958, 2021.
PubMed
4) Lau K, et al : Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement : insights from an internet registry in the study of a rare cancer. Chest 140 : 1312-1318, 2011.
PubMed
5) Stacchiotti S, et al : Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts. ESMO Open 6 : 100170, 2021.
 
6) Epelboym Y, et al : Imaging findings in epithelioid hemangioendothelioma. Clin Imaging 58 : 59-65, 2019.
PubMed
7) Errani C, et al : A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer 50 : 644-653, 2011.
PubMed
8) Antonescu CR, et al : Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 52 : 775-784, 2013.
PubMed
9) Righi A, et al : Primary Vascular Tumors of Bone : A Monoinstitutional Morphologic and Molecular Analysis of 427 Cases With Emphasis on Epithelioid Variants. Am J Surg Pathol 44 : 1192-1203, 2020.
 
10) Rosenbaum E, et al : Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets. Mod Pathol 33 : 591-602, 2020.
PubMed
P.101 掲載の参考文献
1) Patel AM, et al : Angiosarcoma in the lung. Chest 103 : 1531-1535, 1993.
PubMed
2) Grafino M, et al : Angiosarcoma of the lung. J Bras Pneumol 42 : 68-70, 2016.
 
3) Penel N, et al : Angiosarcoma : state of the art and perspectives. Crit Rev Oncol Hematol 80 : 257-263, 2011.
PubMed
4) Young RJ, et al : Angiosarcoma. Lancet Oncol 11 : 983-991, 2010.
PubMed
5) Shimabukuro I, et al : Primary pulmonary angiosarcoma presenting with hemoptysis and ground-glass opacity : a case report and literature review. Tohoku J Exp Med 237 : 273-278, 2015.
PubMed
6) Ren Y, et al : Primary pulmonary angiosarcoma : Three case reports and literature review. Thorac Cancer 7 : 607-613, 2016.
PubMed
7) Aozasa K, et al : Angiosarcoma developing from chronic pyothorax. Mod Pathol 7 : 906-911, 1994.
PubMed
8) 千田秀一, ほか : 血管肉腫. 関節外科 31 (4月増刊) : 217-219, 2012.
 
9) Obeso Carillo GA, et al : Primary pulmonary angiosarcoma, an exceptional neoplasm with a poor prognosis : reports of two cases and review of the literature. Gen Thorac Cardiovasc Surg 61 : 643-647, 2013.
PubMed
10) Penel N, et al : Phase II trial of weekly paclitaxel for unresectable angiosarcoma : the ANGIOTAX Study. J Clin Oncol 26 : 5269-5274, 2008.
PubMed
11) Wilson R, et al : Complete radiographic response of primary pulmonary angiosarcomas following gemcitabine and taxotere. Lung Cancer 61 : 131-136, 2008.
PubMed
P.105 掲載の参考文献
1) WHO Classification of Tumours, 4th ed, Vol 7, WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (ed by Travis WD, et al), p127-128, IARC, Lyon, 2015.
 
2) Enzinger & Weiss's Soft Tissue Tumors, 7th ed (Goldblum JR, et al), p1200-1218, Elsevier, Philadelphia, 2020.
 
3) Panigrahi MK, et al : Primary pulmonary synovial sarcoma : A reappraisal. J Cancer Res Ther 14 : 481-489, 2018.
PubMed
4) Travis WD, et al : AFIP Atias of Tumor Pathology, Series 4, Fascicle 29 : Tumors of the Lower Respiratory Tract, p513-517, American Registry of Pathology, Arlington, 2019.
 
5) Ishida H, et al : Primary pulmonary synovial sarcoma with calcification : A case report. Thorac Cancer 10 : 2040-2044, 2019.
PubMed
6) 青木貴徳, ほか : 肺原発滑膜肉腫の1例. 日本臨床外科学会雑誌 78 : 285-290, 2017.
 
7) Wang CH, et al : Diagnosis of a rare primary pulmonary synovial sarcoma with endobronchial ultrasound-guided transbronchial needle aspiration. Thorac Cancer 7 : 684-688, 2016.
PubMed
8) 折茂真実, ほか : 胸腔内原発滑膜肉腫の1例. 日本呼吸器学会誌 6 : 341-345, 2017.
Medical*Online
P.108 掲載の参考文献
1) O'brien JE, Stout AP : Malignant Fibrous Xanthomas. Cancer 17 : 1445-1455, 1964.
PubMed
2) Weiss SW, Enzinger FM : Malignant fibrous histiocytoma : an analysis of 200 cases. Cancer 41 : 2250-2266, 1978.
PubMed
3) Bedrossian CW, et al : Pulmonary malignant fibrous histiocytoma. Light and electron microscopic studies of one case. Chest 75 : 186-189, 1979.
PubMed
4) Fletcher CD : Pleomorphic malignant fibrous histiocytoma : fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16 : 213-228, 1992.
 
5) Fletcher CD, et al : Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas : prognostic relevance of subclassification. J Clin Oncol 19 : 3045-3050, 2001.
 
6) Nakayama R, et al : Gene expression analysis of soft tissue sarcomas : characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol 20 : 749-759, 2007.
PubMed
7) World Health Organization Classification of Tumours, 3rd ed, Vol 5, Pathology and Genetics of Tumours of Soft Tissue and Bone (ed by Fletcher CDM, et al), p120-126, IARC Press, Lyon, 2002.
 
8) Miyashita Y, et al : Primary undifferentiated pleomorphic sarcoma (Malignant fibrous histiocytoma) of the lung : A case report. Clin Case Rep 8 : 33-37, 2020.
 
9) WHO Classification of Tumours, 5th ed, Vol 5, Thoracic Tumours (ed by WHO Classification of Tumours Editorial Board), p262-291, IARC, Lyon, 2021.
 
10) McMillan RR, et al : Recurrence patterns after resection of soft tissue sarcomas of the chest wall. Ann Thorac Surg 96 : 1223-1228, 2013.
PubMed
11) Ogura K, et al : Integrated genetic and epigenetic analysis of myxofibrosarcoma Nat Commun 9 : 2765, 2018.
PubMed
12) Jevremovic V, et al : A rare presentation of myxofibrosarcoma as a Pancoast tumor : a case report. J Med Case Rep 11 : 61, 2017.
PubMed
13) Higuchi M, et al : Successful Multidisciplinary Treatment for Aggressive Primary Pulmonary Undifferentiated Pleomorphic Sarcoma. Case Rep Oncol 13 : 385-391, 2020.
PubMed
14) Qorbani A, Nelson SD : Primary pulmonary undifferentiated pleomorphic sarcoma (PPUPS). Autops Case Rep 9 : e2019110, 2019.
PubMed
15) Look Hong NJ, et al : Prognostic factors and outcomes of patients with myxofibrosarcoma. Ann Surg Oncol 20 : 80-86, 2013.
PubMed
P.114 掲載の参考文献
1) WHO Classification of Tumours, 5th ed, Vol 5, Thoracic Tumours (ed by WHO Classification of Tumours Editorial Board), International Agency for Research on Cancer, Lyon, 2021.
 
2) WHO Classification of Tumours, 5th ed, Vol 3, Soft Tissue and Bone Tumours (ed by WHO Classification of Tumours Editorial Board), International Agency for Research on Cancer, Lyon, 2020.
 
3) 臨床・病理 肺癌取扱い規約 [第8版補訂版] (日本肺癌学会編), 金原出版, 2021.
 
4) 整形外科・病理 悪性軟部腫瘍取扱い規約 [第3版] (日本整形外科学会 骨・軟部腫瘍委員会編), 金原出版, 2002.
 
5) Rao N, et al : Intrapulmonary solitary fibrous tumors clinicopathologic and immunohistochemical study of 24 cases. Am J Surg Pathol 37 : 155-166, 2013.
PubMed
6) Thway K, et al : The Current Status of Solitary Fibrous Tumor : Diagnostic Features, Variants, and Genetics. Int J Surg Pathol 24 : 281-292, 2016.
PubMed
7) Kalebi AY, et al : Surgically cured hypoglycemia secondary to pleural solitary fibrous tumour : Case report and update review on the doege-potter syndrome. J Cardiothorac Surg 4 : 45, 2009.
PubMed
8) Lee JC, Fletcher CDM : Malignant fat-forming solitary fibrous tumor (so-called "lipomatous hemangiopericytoma") : Clinicopathologic analysis of 14 cases. Am J Surg Pathol 35 : 1177-1185, 2011.
PubMed
9) Yatabe Y, et al : Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer. J Thorac Oncol 14 : 377-407, 2019.
PubMed
10) Demicco EG, Meyer C : Solitary fibrous tumor. In : UpToDate, Waltham, last updated : Nov 18, 2020.
 
P.117 掲載の参考文献
1) Isaacson P, Wright DH : Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 52 : 1410-1416, 1983.
PubMed
2) Borie R, et al : Lymphoproliferative Disorders of the Lung. Respiration 94 : 157-175, 2017.
PubMed
3) Pina-Oviedo S, et al : Primary Pulmonary Lymphomas. Adv Anat Pathol 22 : 355-375, 2015.
PubMed
4) Borie R, et al : Clinical characteristics and prognostic factors of pulmonary MALT lymphoma. Eur Respir J 34 : 1408-1416, 2009.
PubMed
5) Borie R, et al : No evidence for a pathogen associated with pulmonary MALT lymphoma : a metagenomics investigation. Infect Agent Cancer 16 : 10, 2021.
PubMed
6) 佐藤篤彦 : BALT (bronchus-associated lymphoid tissue) の基礎的, 臨床的展望. 日本呼吸器学会雑誌 38 : 3-11, 2000.
Medical*Online
7) Sanguedolce F, et al : Primary Pulmonary B-Cell Lymphoma : A Review and Update. Cancers (Basel) 13 : 415, 2021.
PubMed
8) Deng W, et al : Pulmonary MALT Lymphoma has variable features on CT. Sci Rep 9 : 8657, 2019.
 
9) Albano D, et al : Pulmonary mucosa-associated lymphoid tissue lymphoma : 18F-FDG PET/CT and CT findings in 28 patients. Br J Radiol 90 : 20170311, 2017.
PubMed
10) Ferraro P, et al : Primary non-Hodgkin's lymphoma of the lung. Ann Thorac Surg 69 : 993-997, 2000.
PubMed
11) Sammassimo S, et al : A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG). Hematol Oncol 34 : 177-183, 2016.
 
12) Zucca E, Bertoni F : The spectrum of MALT lymphoma at different sites : biological and therapeutic relevance. Blood 127 : 2082-2092, 2016.
PubMed
13) リンパ腫 辺縁帯リンパ腫. 造血器腫瘍診療ガイドライン [2018年版補訂版] (日本血液学会編), 金原出版, 2020.
 
P.121 掲載の参考文献
1) Nakamura S, et al : Intravascular large B-cell lymphoma. In : WHO Classification of Tumours, Revised 4th ed, Vol 2, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed by Swerdlow SH, et al), p317-318, International Agency for Research on Cancer, Lyon, 2017.
 
2) Murase T, et al : Intravascular large B-cell lymphoma (IVLBCL) : a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109 : 478-485, 2007.
 
3) Ponzoni M, et al : Definition, diagnosis, and management of intravascular large B-cell lymphoma : proposals and perspectives from an international consensus meeting. J Clin Oncol 25 : 3168-3173, 2007.
 
4) Shimada K, et al : Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol 10 : 895-902, 2009.
 
5) Gascoyne RD, et al : Diffuse large B-cell lymphoma (DLBCL), NOS. In : WHO Classification of Tumours, Revised 4th ed, Vol 2, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed by Swerdlow SH, et al), p291-297, International Agency for Research on Cancer, Lyon, 2017.
 
6) Schrader AMR, et al : High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma. Blood 131 : 2086-2089, 2018.
 
7) Tomita A, et al : Detection of Recurrent Genetic Mutations in Intravascular Large B-Cell Lymphoma By Comprehensive Genetic Analyses Using Peripheral Blood Circulating Cell-Free DNA. Blood 130 (Suppl 1) : 1452, 2017.
 
8) Suehara Y, et al : Liquid biopsy for the identification of intravascular large B-cell lymphoma. Haematologica 103 : e241-e244, 2018.
 
9) Shimada K, et al : Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma. Blood 137 : 1491-1502, 2021.
 
10) Ferreri AJ, et al : Intravascular lymphoma : clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 127 : 173-183, 2004.
 
11) Matsue K, et al : Random skin biopsy and bone marrow biopsy for diagnosis of intravascular large B cell lymphoma. Ann Hematol 90 : 417-421, 2011.
 
12) Shimada K, et al : Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 26 : 3189-3195, 2008.
 
13) Shimada K, et al : Central nervous system involvement in intravascular large B-cell lymphoma : a retrospective analysis of 109 patients. Cancer Sci 101 : 1480-1486, 2010.
 
14) Matsue K, et al : High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma. Cancer 117 : 4512-4521, 2011.
 
15) Shimada K, et al : Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL) : a multicentre, single-arm, phase 2 trial. Lancet Oncol 21 : 593-602, 2020.
 
P.125 掲載の参考文献
1) Howlett TA, et al : Diagnosis and management of ACTH-dependent Cushing's syndrome : comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) 24 : 699-713, 1986.
PubMed
2) Oldfield EH, et al : Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 325 : 897-905, 1991.
PubMed
3) Wajchenberg BL, et al : Ectopic ACTH syndrome. J Steroid Biochem Mol Biol 53 : 139-151, 1995.
PubMed
4) Lacroix A, et al : Cushing's syndrome. Lancet 386 : 913-927, 2015.
PubMed
5) Maragliano R, et al : ACTH-secreting pancreatic neoplasms associated with Cushing syndrome : clinicopathologic study of 11 cases and review of the literature. Am J Surg Pathol 39 : 374-382, 2015.
PubMed
6) Davi' MV, et al : Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors : a multicenter study. Eur J Endocrinol 176 : 453-461, 2017.
PubMed
7) Goto K, et al : Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus. Mod Pathol 14 : 985-994, 2001.
PubMed
8) Chaer R, et al : Primary neuroendocrine tumors of the thymus. Ann Thorac Surg 74 : 1733-1740, 2002.
PubMed
9) Isidori AM, et al : The ectopic adrenocorticotropin syndrome : clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 91 : 371-377, 2006.
PubMed
10) Brown WH : A Case of Pluriglandular Syndrome : "Diabetes of Bearded Women". Lancet 212 : 1022-1023, 1928.
 
11) Cushing H : The basophilic adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50 : 138-195, 1932.
 
12) Meador CK, et al : Cause of Cushing's syndrome in patients with tumors arising from "nonendocrine" tissue. J Clin Endocrinol Metab 22 : 693-703, 1962.
 
13) Alexandraki KI, Grossman AB : The ectopic ACTH syndrome. Rev Endocr Metab Disord 11 : 117-126, 2010.
PubMed
14) Okumura T, et al : ACTH-producing thymic neuroendocrine tumor initially presenting as psychosis : A case report and literature review. Thorac Cancer 10 : 1648-1653, 2019.
PubMed
15) Pass HI, et al : Management of the ectopic ACTH syndrome due to thoracic carcinoids. Ann Thorac Surg 50 : 52-57, 1990.
PubMed
16) Daniels CE, et al : The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Chest 131 : 255-260, 2007.
PubMed
17) Nieman LK, et al : Treatment of Cushing's Syndrome : An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 100 : 2807-2831, 2015.
 
18) Pivonello R, et al : Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3) : amulticentre phase III study with a double-blind, randomised withdrawal phase. Lancet Diabetes Endocrinol 8 : 748-761, 2020.
 
19) Ejaz S, et al : Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion : the University of Texas MD Anderson Cancer Center Experience. Cancer 117 : 4381-4389, 2011.
PubMed
20) Small M, et al : Thromboembolic complications in Cushing's syndrome. Clin Endocrinol (Oxf) 19 : 503-511, 1983.
 
P.129 掲載の参考文献
1) List AF, et al : The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. J Clin Oncol 4 : 1191-1198, 1986.
PubMed
2) Maurer LH, et al : Human neurophysins in carcinoma of the lung : relation to histology, disease stage, response rate, survival, and syndrome of inappropriate antidiuretic hormone secretion. Cancer Treat Rep 67 : 971-976, 1983.
PubMed
3) Harrison's Principles of Internal Medicine, 20th ed (ed by Jameson JL, et al), McGraw Hill, New York, 2018.
 
4) バソプレシン分泌過剰症 (SIADH) の診断と治療の手引き (平成30年度改訂). 日本内分泌学会雑誌 95 (Suppl) : 18-20, 2019.
 
5) Schrier RW, et al : Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355 : 2099-2112, 2006.
PubMed
6) Berl T, et al : Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol 21 : 705-712, 2010.
PubMed
P.133 掲載の参考文献
1) Kanagalingam S, Miller NR : Horner syndrome : clinical perspectives. Eye Brain 7 : 35-46, 2015.
PubMed
2) Marulli G, et al : Superior sulcus tumors (Pancoast tumors). Ann Transl Med 4 : 239, 2016.
PubMed
3) Maloney WF, et al : Evaluation of the causes and accuracy of pharmacologic localization in Horner's syndrome. Am J Ophthalmol 90 : 394-402, 1980.
PubMed
4) 南貴博, ほか : Horner症候群を初発症状としたびまん型悪性胸膜中皮腫の1例. 日本呼吸器学会雑誌 37 : 287-290, 1999.
Medical*Online
5) Shanmugathas N, et al : Pancoast tumour presenting as shoulder pain with Horner's syndrome. BMJ Case Rep 12 : e227873, 2019.
PubMed
6) Attar S, et al : Superior sulcus (Pancoast) tumor : experience with 105 patients. Ann Thorac Surg 66 : 193-198, 1998.
PubMed
7) Trobe JD : The Evaluation of Horner Syndrome. J Neuroophthalmol 30 : 1-2, 2010.
PubMed
8) Knyazer B, et al : Iatrogenic Horner Syndrome : Etiology, Diagnosis and Outcomes. Isr Med Assoc J 19 : 34-38, 2017.
 
P.136 掲載の参考文献
1) Hunter W : The history of an aneurysm of the aorta, with some remarks on aneurysms in general. Med Obser Inq 1 : 323-357, 1757.
 
2) Wilson LD, et al : Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med 356 : 1862-1869, 2007.
PubMed
3) Yu JB, et al : Superior vena cava syndrome-a proposed classification system and algorithm for management. J Thorac Oncol 3 : 811-814, 2008.
PubMed
4) Lepper PM, et al : Superior vena cava syndrome in thoracic malignancies. Respir Care 56 : 653-666, 2011.
PubMed
5) Rowell NP, Gleeson FV : Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus : a systematic review. Clin Oncol (R Coll Radiol) 14 : 338-351, 2002.
PubMed
6) Armstrong BA, et al : Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys 13 : 531-539, 1987.
PubMed
7) Takeuchi Y, et al : Evaluation of stent placement for vena cava syndrome : phase II trial and phase III randornized controlled trial. Support Care Cancer 27 : 1081-1088, 2019.
PubMed
8) Schraufnagel DE, et al : Superior vena caval obstruction. Is it a medical emergency? Am J Med 70 : 1169-1174, 1981.
PubMed
P.140 掲載の参考文献
1) Pancoast HK : Superior pulmonary sulcus tumor. JAMA 99 : 1391-1396, 1932.
 
2) Detterbeck FC : Pancoast (superior sulcus) tumors. Ann Thorac Surg 63 : 1810-1818, 1997.
PubMed
3) Panagopoulos N, et al : Pancoast tumors : characteristics and preoperative assessment. J Thorac Dis 6 (Suppl 1) : S108-115, 2014.
 
4) Foroulis CN, et al : Superior sulcus (Pancoast) tumors : current evidence on diagnosis and radical treatment. J Thorac Dis 5 (Suppl 4) : S342-358, 2013.
 
5) Rusch VW : Management of Pancoast tumours. Lancet Oncol 7 : 997-1005, 2006.
PubMed
6) Rusch VW, et al : Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas : long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 25 : 313-318, 2007.
 
7) Kunitoh H, et al : Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers : report of Japan Clinical Oncology Group trial 9806. J Clin Oncol 26 : 644-649, 2008.
PubMed
8) Kawaguchi K, et al : A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801). Lung Cancer 104 : 79-84, 2017.
PubMed
9) Marino P, et al : Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis. Cancer 76 : 593-601, 1995.
PubMed
10) Antonia SJ, et al : Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC. N Engl J Med 379 : 2342-2350, 2018.
PubMed
11) Van Houtte P, et al : External radiation in the management of superior sulcus tumor. Cancer 54 : 223-227, 1984.
PubMed
12) がんの痛みからの解放 : WHO方式がん疼痛治療法 [第2版] (世界保健機関編武田文和訳), 金原出版, 1996.
 
P.144 掲載の参考文献
1) Bruce DM, et al : Lymphangitis carcinomatosa : a literature review. J R Coll Surg Edinb 41 : 7-13, 1996.
PubMed
2) Ajith Kumar AK, Sumant M : Lymphangitic Carcinornatosis. StatPearls Publishing, Treasure Island ; 2021 Jan. [updated 2021 Jul 10]
 
3) Klimek M : Pulmonary lymphangitis carcinomatosis : systematic review and meta-analysis of case reports, 1970-2018. Postgrad Med 131 : 309-318, 2019.
PubMed
4) Grenier P, et al : Chronic diffuse infiltrative lung disease : determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis. Radiology 191 : 383-390, 1994.
PubMed
5) Janower ML, Blennerhassett JB : Lymphangitic spread of metastatic cancer to the lung. A radiologic-pathologic classification. Radiology 101 : 267-273, 1971.
 
6) 大江裕一郎 : 癌性リンパ管症の診かた. 治療 85 : 1942-1946, 2003.
Medical*Online
7) 佐藤隆, ほか : 肺の癌性リンパ管症の臨床病理学的検討-その発生と進展様式-. 日本胸部疾患学会雑誌 26 : 1243-1248, 1988.
 
8) 高遼, 高橋和久 : がん性リンパ管症. 呼吸 31 : 1135-1138, 2012.
Medical*Online
9) Prakash P, et al : FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis. AJR Am J Roentgenol 194 : 231-236, 2010.
PubMed
10) 伊地知佳世, ほか : 癌性リンパ管症の診断と治療のすすめかた. Medical Practice 27 : 653-658, 2010.
Medical*Online
P.147 掲載の参考文献
1) Travis WD, et al : The 2015 World Health Organization Classification of Lung Tumors : Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol 10 : 1243-1260, 2015.
PubMed
2) Wilson RW, Moran CA : Primary melanoma of the lung : a clinicopathologic and immunohistochemical study of eight cases. Am J Surg Pathol 21 : 1196-1202, 1997.
 
3) Ost D, et al : Primary pulmonary melanoma : case report and literature review. Mayo Clin Proc 74 : 62-66, 1999.
PubMed
4) Dountsis A, et al : Primary Malignant Melanoma of the Lung : A Case Report. World J Surg Oncol 1 : 26, 2003.
 
5) Kundranda MN, et al : Primary malignant melanoma of the lung : a case report and review of the literature. Clin Lung Cancer 7 : 279-281, 2006.
 
6) Maeda R, et al : Primary malignant melanoma of the lung with rapid progression. Gen Thorac Cardiovasc Surg 57 : 671-674, 2009.
PubMed
7) Mahowald MK, et al : Long-term survival after pneumonectomy for primary pulmonary malignant melanoma. Ann Thorac Surg 99 : 1428-1430, 2015.
PubMed
8) Peng J, et al : Primary malignant melanoma of the lung : A case report and literature review. Medicine (Baltimore) 96 : e8772, 2017.
 
9) Yunce M, et al : Primary malignant melanoma of the lung : a case report of a rare tumor and review of the literature. J Community Hosp Intern Med Perspect 8 : 29-31, 2018.
 
10) Azuma Y, et al : Primary pulmonary melanoma diagnosed by semi-rigid thoracoscopy. Thorac Cancer 9 : 1528-1529, 2018.
PubMed
11) Figueroa Rodriguez F, et al : Primary Pulmonary Malignant Melanoma Found While Evaluating New Onset Cough : A Case Presentation and Literature Review. Case Rep Pulmonol 2019 : 3867831, 2019.
PubMed
12) Kyriakopoulos C, et al : Primary Pulmonary Malignant Melanoma : Report of an Important Entity and Literature Review, Case Rep Oncol Med 2017 : 8654326, 2017.
PubMed
13) Feng Y, et al : Pulmonary melanoma and "crazy paving" patterns in chest images : a case report and literature review. BMC Cancer 16 : 592, 2016.
PubMed
14) Kim SR, et al : Pulmonary malignant melanoma with distant metastasis assessed by positron emission tomography-computed tomography. Thorac Cancer 7 : 503-507, 2016.
PubMed
15) Filippini A, et al : Dark sputum : An atypical presentation of primary pulmonary malignant melanoma. Respir Med Case Rep 15 : 118-120, 2015.
PubMed
16) Hwang KB, et al : Primary Pulmonary Malignant Melanoma : An Unexpected Tumor. Tuberc Respir Dis (Seoul) 78 : 272-275, 2015.
PubMed
17) Zhang X, et al : Primary malignant melanoma of left lower lobe of lung : A case report and review of the literature. Oncol Lett 10 : 528-530, 2015.
 
18) Ouarssani A, et al : Malignant melanoma of the lung : a case report. Pan Afr Med J 11 : 68, 2012.
 
19) Gong L, et al : Primary pulmonary malignant melanoma : a clinicopathologic study of two cases. Diagn Pathol 7 : 123, 2012.
PubMed
20) Neri S, et al : Malignant melanoma of the lung : report of two cases. Ann Thorac Cardiovasc Surg 17 : 170-173, 2011.
PubMed
21) De Wilt JH, et al : Isolated melanoma in the lung where there is no known primary site : metastatic disease or primary lung tumour? Melanoma Res 15 : 531-537, 2005.
PubMed
22) Kunkel OF, Torrey E : Report of a case of primary melanotic sarcoma of lung presenting difficulties in differentiating from tuberculosis. N Y State J Med 16 : 198-201, 1916.
 
23) Bajetta E, et al : Metastatic melanoma : chemotherapy. Semin Oncol 29 : 427-445, 2002.
PubMed
24) Jensen OA, EqedorfJ : Primary malignant melanoma of the lung. Scand J Respir Dis 48 : 127-135, 1967.
PubMed
25) Goldman JL, et al : The presence of melanocytes in the human larynx. Laryngoscope 82 : 824-835, 1972.
PubMed
26) Fowler M, Sutherland HD : Malignant melanoma of the aesophagus. J Pathol Bacteriol 64 : 473-477, 1952.
PubMed
27) Reed RJ 3rd, Kent EM : Solitary Pulmonary Melanomas : Two Case Reports. J Thorac Cardiovasc Surg 48 : 226-231, 1964.
PubMed
28) Allen MS Jr, Drash EC : Primary melanoma of the lung. Cancer 21 : 154-159, 1968.
PubMed
29) Reid JD, Mehta VT : Melanoma of the lower respiratory tract. Cancer 19 : 627-631, 1966.
 
30) Yang C, et al : Lung-only melanoma : UV mutational signature supports origin from occuit cutaneous primaries and argues against the concept of primary pulmonary melanoma. Mod Pathol 33 : 2244-2255, 2020.
 
31) Landgraf LG, et al : Primary Melanoma of the Lung Treated with Surgery, Dabrafenib and Trametinib. Case Rep Oncol 13 : 789-792, 2020.
PubMed
P.151 掲載の参考文献
1) William J, et al : Lymphoproliferative neoplasms of the lung : a review. Arch Pathol Lab Med 137 : 382-391, 2013.
 
2) 楠本昌彦 : まれな肺腫瘍の画像診断. 肺癌 55 : 1037-1044, 2015.
Medical*Online
3) Liebow AA, et al : Lymphomatoid granulomatosis. Hum Pathol 3 : 457-558, 1972.
PubMed
4) 稲垣宏, 正木彩子 : 肺リンパ腫・リンパ腫様肉芽腫症・膿胸関連リンパ腫. 日本臨牀 73 (増刊 8 : リンパ腫学) : 638-644, 2015.
 
5) Song JY, et al : Lymphomatoid granulomatosis-a single institute experience : pathologic findings and clinical correlations. Am J Surg Pathol 39 : 141-156, 2015.
PubMed
6) Lee JS, et al : Lymphomatoid granulomatosis : radiologic features and pathologic correlations. AJR Am J Roentgenol 175 : 1335-1339, 2000.
PubMed
7) Pittaluga S, et al : Lymphomatoid granulomatosis. In : WHO Classification of Tumours, 4th ed, Vol 2, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed by Swerdlow SH, et al), p247-249, IARC, Lyon, 2008.
 
8) Iuchi K, et al : Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer 60 : 1771-1775, 1987.
PubMed
9) Nakatsuka S, et al : Pyothorax-associated lymphoma : a review of 106 cases. J Clin Oncol 20 : 4255-4260, 2002.
 
10) Castellino RA, et al : Hodgkin disease : contributions of chest CT in the initial staging evaluation. Radiology 160 : 603-605, 1986.
PubMed
11) Khoury MB, et al : Role of chest CT in non-Hodgkin lymphoma. Radiology 158 : 659-662, 1986.
PubMed
12) Berkman N, et al : Pulmonary involvement in lymphoma. Leuk Lymphoma 20 : 229-237, 1996.
PubMed
13) Rose RM, et al : Endobronchial involvement with non-Hodgkin's lymphoma. A clinical-radiologic analysis. Cancer 57 : 1750-1755, 1986.
PubMed
P.154 掲載の参考文献
1) がん情報サービス : がん種別統計情報 白血病, 2017年. [https://ganjoho.jp/reg_stat/statistics/stat/cancer/27_aml.html] (2021年10月閲覧)
 
2) Chaoui D, et al : Incidence and prognostic value of respiratory events in acute leukemia. Leukemia 18 : 670-675, 2004.
PubMed
3) Azoulay E, et al : Acute respiratory failure in immunocompromised adults. Lancet Respir Med 7 : 173-186, 2019.
PubMed
4) Lucena CM, et al : Pulmonary complications in hematopoietic SCT : a prospective study. Bone Marrow Transplant 49 : 1293-1299, 2014.
PubMed
5) 日本癌治療学会 : 2 発熱性好中球減少症の定義とリスク. [http://www.jsco-cpg.jp/guideline/30.html] (2021年10月閲覧)
 
6) Baden LR, et al : Prevention and Treatment of Cancer-Related Infections, Version 2. 2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 14 : 882-913, 2016.
 
7) Azoulay E, et al : Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med 46 : 298-314, 2020.
PubMed
8) がん情報サービス : 慢性リンパ性白血病/小リンパ球性リンパ腫 患者数 (がん統計), 2017年. [https://ganjoho.jp/public/cancer/CLL/index.html] (2021年10月閲覧)
 
9) がん情報サービス : 成人T細胞白血病リンパ腫 患者数 (がん統計), 2017年. [https://ganjoho.jp/public/cancer/ATL/patients.html] (2021年10月閲覧)
 
10) Einsiedel L, et al : Human T-cell leukaemia virus type 1 associated pulmonary disease : clinical and pathological features of an under-recognised complication of HTLV-1 infection. Retrovirology 18 : 1, 2021.
 
11) Shroff GS, et al : Leukemic Involvement in the Thorax. Radiographics 39 : 44-61, 2019.
PubMed
12) Smith LJ, Katzenstein AL : Pathogenesis of massive pulmonary hemorrhage in acute leukemia. Arch Intern Med 142 : 2149-2152, 1982.
PubMed
13) Soubani AO, et al : Pulmonary complications of bone marrow transplantation. Chest 109 : 1066-1077, 1996.
PubMed
14) Haider S, et al : Noninfectious pulmonary complications of haematopoietic stem cell transplantation. Eur Respir Rev 29 : 190119, 2020.
PubMed
15) Zhang Z, et al : Epidemiology, Risk Factors and Outcomes of Diffuse Alveolar Hemorrhage after Hematopoietic Stem Cell Transplantation. Chest 159 : 2325-2333, 2021.
PubMed
16) Vahdat L, et al : Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia : impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 84 : 3843-3849, 1994.
PubMed
17) Patatanian E, Thompson DF : Retinoic acid syndrome : a review. J Clin Pharm Ther 33 : 331-338, 2008.
PubMed
18) 日本血液学会 : 造血器腫瘍診療ガイドライン [2018年版補訂版] : 第I章 白血病, 2 急性前骨髄球性白血病. [http://www.jshem.or.jp/gui-hemali/1_2.html] (2021年10月閲覧)
 
19) Ishii H, et al : Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest 136 : 1348-1355, 2009.
PubMed
20) Ishii H, et al : Clinical features of secondary pulmonary alveolar proteinosis : pre-mortem cases in Japan. Eur Respir J 37 : 465-468, 2011.
PubMed
21) Kimura I, et al : Presence of antibodies against adult T cell leukemia antigen in the patients with chronic respiratory diseases. Acta Med Okayama 40 : 281-284, 1986.
 
22) Weatherald J, et al : Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors. Eur Respir J 56 : 2000279, 2020.
PubMed
P.160 掲載の参考文献
1) Nakao YK, et al : Seronegative Lambert-Eaton myasthenic syndrome : study of 110 Japanese patients. Neurology 59 : 1773-1775, 2002.
PubMed
2) Wirtz PW, et al : HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome. J Neuroimmunol 159 : 230-237, 2005.
PubMed
3) O'Neill JH, et al : The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 111 (Pt 3) : 577-596, 1988.
 
4) Titulaer MJ, et al : Screening for small-cell lung cancer : a follow-up study of patients with Lambert-Eaton myasthenic syndrome. J Clin Oncol 26 : 4276-4281, 2008.
PubMed
5) Liu Y, et al : Clinical characteristics and long term follow-up of Lambert-Eaton myasthenia syndrome in patients with and without small cell lung cancer. J Clin Neurosci 65 : 41-45, 2019.
PubMed
6) Burns TM, et al : Oculobulbar involvement is typical with Lambert-Eaton myasthenic syndrome. Ann Neurol 53 : 270-273, 2003.
PubMed
7) Oh SJ, et al : Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome. Muscle Nerve 32 : 515-520, 2005.
PubMed
8) Iams WT, et al : Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes. J Thorac Oncol 14 : 1970-1981, 2019.
PubMed
9) Fukuda T, et al : Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. Ann Neurol 53 : 21-28, 2003.
PubMed
10) Zalewski NL, et al : P/Q- and N-type calciしlm-channel antibodies : Oncological, neurological, and serological accompaniments. Muscle Nerve 54 : 220-227, 2016.
 
11) Titulaer MJ, et al : SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome : frequency and relation with survival. J Clin Oncol 27 : 4260-4267, 2009.
PubMed
12) Titulaer MJ, et al : Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. J Clin Oncol 29 : 902-908, 2011.
PubMed
13) Oh SJ, et al : Amifampridine phosphate (Firdapse(R)) is effective and safe in a phase 3 clinical trial in LEMS. Muscle Nerve 53 : 717-725, 2016.
 
14) Maddison P, et al : Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer. J Neurol Neurosurg Psychiatry 70 : 212-217, 2001.
PubMed
15) Maddison P, et al : Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 88 : 1334-1339, 2017.
PubMed
16) Nakatani Y, et al : Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer. Case Rep Neurol 10 : 346-352, 2018.
 
17) Morimoto T, et al : Paraneoplastic Sensory Polyneuropathy Related to Anti-PD-L1-including Anticancer Treatment in a Patient with Lung Cancer. Intern Med 60 : 1577-1581, 2021.
 
18) Vogrig A, et al : Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors. Neurol Neuroimmunol Neuroinflamm 6 : e604, 2019.
PubMed

XI 縦隔疾患

P.166 掲載の参考文献
1) Bernard C, et al : Thymoma associated with autoimmune diseases : 85 cases and literature review. Autoimmun Rev 15 : 82-92, 2016.
PubMed
2) 正岡昭, 山川洋右 : 胸腺腫と自己免疫疾患-特に重症筋無力症と赤芽球癆. 外科診療 33 : 1584-1591, 1991.
 
3) Nishizawa T, et al : Good Syndrome Occurred in a Patient a Prolonged Time after Thymectomy : A Case Report and Literature Review of Cases in Japan. J Gen Fam Med 17 : 238-243, 2016.
 
4) Kelesidis T, Yang O : Good's syndrome remains a mystery after 55 years : A systematic review of the scientific evidence. Clin Immunol 135 : 347-363, 2010.
 
5) Hermaszewski RA, Webster AD : Primary hypogammaglobulinaemia : a survey of clinical manifestations and complications. Q J Med 86 : 31-42, 1993.
PubMed
6) Tarr PE, et al : Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore) 80 : 123-133, 2001.
PubMed
P.170 掲載の参考文献
1) Shimosato Y, et al : Anatomy and anatomic compartments of the mediastinum. In : AFIP Atlas of Tumor Pathology, 4th Series, Fascicle 11, Tumors of the Mediastinum, p1-18, ARP Press, Silver Spring, 2010.
 
2) Suster S, Rosai J : Thymus. In : Histology for Pathologists, 4th ed (ed by Mills SE), p541-562, LWW Press, Philadelphia, 2012.
 
3) Shimosato Y, et al : Non-neoplastic conditions of the thymus. In : AFIP Atlas of Tumor Pathology, 4th Series, Fascicle 11, Tumors of the Mediastinum, p271-280, ARP Press, Silver Spring, 2010.
 
4) Lack EE : Thymic hyperplasia with massive enlargement : report of two cases with review of diagnostic criteria. J Thorac Cardiovasc Surg 81 : 741-746, 1981.
PubMed
5) Ricci C, et al : True thymic hyperplasia : a clinicopathological study. Ann Thorac Surg 47 : 741-745, 1989.
PubMed
6) Carmosino L, et al : Thymic hyperplasia following successful chemotherapy. A report of two cases and review of the literature. Cancer 56 : 1526-1528, 1985.
PubMed
7) Marx A, et al : Type B1 thymoma. In : WHO Classificationof Tumours, 5th ed, Vol 5, Thoracic Tumours (ed by WHO Classification of Tumours Editorial Board), p332-335, IARC Press, Lyon, 2021.
 
8) Eimoto T, et al : Nonneoplastic and nonhyperplastic thymus in myasthenia gravis. An immunohistochemical study with double immunoenzymatic labeling of basement membrane and cellular components. Am J Clin Pathol 94 : 36-43, 1990.
PubMed
9) Marx A, et al : The pathology of the thymus in myasthenia gravis. Mediastinum 2 : 1-14, 2018.
 
10) Hohlfeld R, Wekerle H : Reflections on the "intrathymic pathogenesis" of myasthenia gravis. J Neuroimmunol 201-202 : 21-27, 2008.
 
11) Inagaki H, et al : Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J Pathol 160 : 1435-1443, 2002.
PubMed
12) Parrens M, et al : Mucosa-associated lymphoid tissue of the thymus hyperplasia vs lymphoma. Am J Clin Pathol 117 : 51-56, 2002.
PubMed
P.175 掲載の参考文献
1) WHO Classification of Tumours, 5th ed, Vol 5, Thoracic Tumours (ed by WHO Classification of Tumours Editorial Board), IARC, Lyon, 2021.
 
2) Koizumi T, et al : National incidence and initial therapy for thymic carcinoma in Japan : based on analysis of hospital-based cancer registry data, 2009-2015. Jpn J Clin Oncol 50 : 434-439. 2020.
 
3) Hishida T, et al : Long-term outcome and prognostic factors of surgically treated thymic carcinoma : results of 306 cases from a Japanese Nationwide Database Study. Eur J Cardiothorac Surg 49 : 835-841, 2016.
PubMed
4) Saito M, et al : The genomic and epigenomic landscape in thymic carcinoma. Carcinogenesis 38 : 1084-1091, 2017.
PubMed
5) Kelly RJ, et al : Thymic malignancies : from clinical management to targeted therapies. J Clin Oncol 29 : 4820-4827, 2011.
PubMed
6) Fukumoto K, et al : The utility of [18F] -fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours. Eur J Cardiothorac Surg 42 : e152-156, 2012.
PubMed
7) 肺癌診療ガイドライン-悪性胸膜中皮腫・胸腺腫瘍含む- [2020年版] (日本肺癌学会編), 金原出版, 2021.
 
8) Guerrera F, et al : Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis : a European Society of Thoracic Surgeons Thymic Working Group Study. Eur J Cardiothorac Surg 60 : 881-887, 2021.
 
9) Nakagawa K, et al : Is Thymomectomy Alone Appropriate for Stage I (T1N0M0) Thymoma? Results of a Propensity-Score Analysis. Ann Thorac Surg 101 : 520-526, 2016.
 
10) Friedant AJ, et al : Minimally Invasive versus Open Thymectomy for Thymic Malignancies : Systematic Review and Meta-Analysis. J Thorac Oncol 11 : 30-38, 2016.
PubMed
11) Korst RJ, et al : Neoadjuvant chemoradiotherapy for locally advanced thymic tumors : a phase II, multi-institutional clinical trial. J Thorac Cardiovasc Surg 147 : 36-44, 46.e1, 2014.
 
12) Hirai F, et al : A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma : WJOG4207L. Ann Oncol 26 : 363-368, 2015.
PubMed
13) Inoue A, et al : Phase II study of Amrubicin combined with carboplatin for thymic carcinoma and invasive thymoma : North Japan Lung Cancer group study O803. J Thorac Oncol 9 : 1805-1809, 2014.
 
14) Sato J, et al : Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA) : a multicentre, phase 2 trial. Lancet Oncol 21 : 843-850, 2020.
PubMed
15) Omasa M, et al : Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors : the Japanese Association for Research on the Thymus Database Study. Cancer 121 : 1008-1016, 2015.
 
P.178 掲載の参考文献
1) Moreira AL, et al : Mature and immature teratoma. In : WHO Classification of Tumours, 4th ed, Vol 7, WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (ed by Travis WD, et al), p257-259, IARC, Lyon, 2015.
 
2) Morikawa K, et al : Rapid growth of a mature mediastinal teratoma in a middle-aged woman : A case report. Radiol Case Rep 15 : 1870-1874, 2020.
 
3) Kuroda H, et al : Resection of a ruptured mature cystic teratoma diagnosed two years after the onset of perforation. World J Surg Oncol 12 : 321, 2014.
PubMed
P.180 掲載の参考文献
1) Lange J, et al : Uber ein Lipon der Thymus. Zentralbl Allg Pathol 27 : 97-101, 1916.
 
2) Benton C, Gerard P : Thymolipoma in a patient with Graves' disease. Case report and review of the literature. J Thorac Cardiovasc Surg 51 : 428-433, 1966.
 
3) Hudacko R, et al : Thymolipoma : clues to pathogenesis revealed by cytogenetics. Ann Diagn Pathol 13 : 185-188, 2009.
PubMed
4) 伊藤祥隆, ほか : 甲状腺機能亢進症を伴った巨大胸腺脂肪腫の1例. 日本呼吸器外科学会雑誌 23 : 955-958, 2009.
 
5) Kondo T, et al : Thymolipoma, report of a case suggesting an origin from thymic true hyperplasia. Int J Surg Pathol 18 : 526-529, 2010.
PubMed
6) 下山孝一郎, ほか : 胸腺過形成を伴った若年胸腺脂肪腫の1切除例. 日本呼吸器外科学会雑誌 34 : 642-647, 2020.
 
7) Campion T, et al : Concurrent thyrolipomatosis and thymolipoma in a patient with myasthenia gravis : a case report and review of the literature. Ann R Coll Surg Engl 103 : e212-e215, 2021.
 
8) Takahashi H, et al : Thymolipoma combined with hyperthyroidism discovered by neurological symptoms. Ann Thorac Cardiovasc Surg 13 : 114-117, 2007.
PubMed
9) Ferreira D, et al : Pure Red Cell Aplasia Associated with Thymolipoma : Complete Anaemia Resolution following Thymectomy. Case Rep Hematol 2018 : 8627145, 2018.
PubMed
10) Guimaraes MD, et al : Thymoma originating in a giant thymolipoma : a rare intrathoracic lesion. Ann Thorac Surg 96 : 1083-1085, 2013.
 
11) Yusuf Mohamud MF, et al : Extensive mediastinal thymolipoma mimicking pulmonary edema. J Surg Case Rep 2020 : rjaa080, 2020.
PubMed
12) Furukawa T, et al : Thoracoscopic resection for mediastinal thymolipoma in a child. Asian J Endosc Surg 12 : 218-221, 2019.
 
13) Park SY, et al : Subxiphoid approach for robotic single-site-assisted thymectomy. Eur J Cardiothorac Surg 58 (Suppl 1) : i34-i38, 2020.
 
P.184 掲載の参考文献
1) 肺癌診療ガイドライン-悪性胸膜中皮腫・胸腺腫瘍含む- [2020年版] (日本肺癌学会編), 金原出版, 2021.
 
2) Nakajima J, et al : Myasthenia gravis with thymic epithelial tumour : a retrospective analysis of a Japanese database. Eur J Cardiothorac Surg 49 : 1510-1515, 2016.
PubMed
3) WHO Classification of Tumours, 4th ed, Vol 7, WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (ed by Travis WD, et al), IARC Press, Lyon, 2015.
 
4) Sakakura N, et al : Diagnostic reproducibility of thymic epithelial tumors using the World Health Organization classification : note for thoracic clinicians. Gen Thorac Cardiovasc Surg 61 : 89-95, 2013.
PubMed
5) Lee SH, et al : Distinguishing between Thymic Epithelial Tumors and Benign Cysts via Computed Tomography. Korean J Radiol 20 : 671-682, 2019.
PubMed
6) Fukumoto K, et al : The utility of [18F] -fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours. Eur J Cardiothorac Surg 42 : e152-156, 2012.
PubMed
7) Masaoka A, et al : Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 : 2485-2492, 1981.
PubMed
8) Detterbeck FC, et al : The IASLC/ITMIG Thymic Epithelial Tumors Staging Project : proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9 (9 Suppl 2) : S65-72, 2014.
 
9) Detterbeck FC, et al : The Masaoka-Koga stage classification for thymic malignancies : clarification and definition of terms. J Thorac Oncol 6 (7 Suppl 3) : S1710-1716, 2011.
 
10) TNM Classification of Malignant Tumours, 8th ed (ed by Brierley JD, et al), John Wiley & Sons, Chichester, Hoboken, 2017.
 
11) AJCC Cancer Staging Manual, 8th ed (ed by Amin MB, et al), Springer Science+Business Media, New York, 2017.
 
12) Fukui T, et al : Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group. Eur J Cardiothorac Surg 49 : 574-579, 2016.
 
13) Kondo K, Monden Y : Therapy for thymic epithelial tumors : a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76 : 878-884 ; discussion 884-885, 2003.
 
14) Kondo K, Monden Y : Lymphogenous and hematogenous metastasis of thymic epithelial tumors. Ann Thorac Surg 76 : 1859-1864 ; discussion 1864-1865, 2003.
 
P.190 掲載の参考文献
1) Davis RD Jr, et al : Primary cysts and neoplasms of the mediastinum : recent changes in clinical presentation, methods of diagnosis, management, and results. Ann Thorac Surg 44 : 229-237, 1987.
PubMed
2) Shimosato Y, et al : AFIP Atlas of Tumor Pathology, 4th Series, Fascicle 11, Tumors of the Mediastinum, p305, ARP Press, Washington DC, 2010.
 
3) Zanca P, et al : True congenital mediastinal thymic cyst. Pediatrics 36 : 615-619, 1965.
PubMed
4) Suster S, Rosai J : Multilocular thymic cyst : an acquired reactive process. Study of 18 cases. Am J Surg Pathol 15 : 388-398, 1991.
PubMed
5) Nakamura S, et al : Multilocular thymic cyst associated with thymoma : a clinicopathologic study of 20 cases with an emphasis on the pathogenesis of cyst formation. Am J Surg Pathol 36 : 1857-1864, 2012.
PubMed
6) Choi YW, et al : Idiopathic multilocular thymic cyst : CT features with clinical and histopathologic correlation. Am J Roentgenol 177 : 881-885, 2001.
 
7) Izumi H, et al : Multilocular thymic cyst associated with follicular hyperplasia : clinicopathologic study of 4 resected cases. Hum Pathol 36 : 841-844, 2005.
PubMed
8) Kondo K, et al : Multilocular thymic cyst associated with Sjogren's syndrome. Ann Thorac Surg 72 : 1367-1369, 2001.
PubMed
9) Weissferdt A, Moran CA : Thymic carcinoma associated with multilocular thymic cyst : a clinicopathologic study of 7 cases. Am J Surg Pathol 35 : 1074-1079, 2011.
PubMed
10) Yoon SH, et al : Incidental Anterior Mediastinal Nodular Lesions on Chest CT in Asymptomatic Subjects. J Thorac Oncol 13 : 359-366, 2018.
PubMed
11) Yano M, et al : Clinicopathological analysis of small-sized anterior mediastinal tumors. Surg Today 44 : 1817-1822, 2014.
PubMed
P.193 掲載の参考文献
1) Masaoka A, et al : Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 : 2485-2492, 1981.
PubMed
2) Koga K, et al : A review of 79 thymomas : modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44 : 359-367, 1994.
 
3) Detterbeck FC, et al : The IASLC/ITMIG Thymic Epithelial Tumors Staging Project : proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9 (9 Suppl 2) : S65-72, 2014.
 
4) National Comprehensive Cancer Network (NCCN) Guidelines version 2. 2019. Thymoma and Thyrnic Carcinomas. [https://www.nccn.org/guidelines/category_1] (2021年9月閲覧)
 
5) 胸腺腫瘍診療ガイドライン 2020年版. 肺癌診療ガイドライン-悪性胸膜中皮腫・胸腺腫瘍含む- [2020年版] (日本肺癌学会編), p368-433, 金原出版, 2021.
 
6) 国立がん研究センター希少がんセンター : 胸腺腫・胸腺がん. [https://www.ncc.go.jp/jp/rcc/about/thymoma/index.html] (2021年9月閲覧)
 
7) Okumura M, et al : Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma. Eur J Cardiothorac Surg 56 : 174-181, 2019.
PubMed
8) McGuire LJ, et al : Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. Am J Pathol 131 : 385-390, 1988.
PubMed
9) Cufi P, et al : Thymoma-associated myasthenia gravis : On the search for a pathogen signature. J Autoimmun 52 : 29-35, 2014.
PubMed
10) Cavalcante P, et al : Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis. Neurology 74 : 1118-1126, 2010.
PubMed
11) Rennspiess D, et al : Detection of human polyomavirus 7 in human thymic epithelial tumors. J Thorac Oncol 10 : 360-366, 2015.
PubMed
12) Gokmen-Polar Y, et al : A gene signature to determine metastatic behavior in thymomas. PLoS One 8 : e66047, 2013.
PubMed
13) Kondo K, Monden Y : Therapy for thymic epithelial tumors : a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76 : 878-884 ; discussion 884-885, 2003.
 
14) Yamada Y, et al : Surgical Outcomes of Patients With Stage III Thymoma in the Japanese Nationwide Database. Ann Thorac Surg 100 : 961-967, 2015.
PubMed
15) Okuda K, et al : Thymoma patients with pleural dissemination : nationwide retrospective study of 136 cases in Japan. Ann Thorac Surg 97 : 1743-1748, 2014.
PubMed
16) Murakawa T, et al : Invasive thymoma disseminated into the pleural cavity : mid-term results of surgical resection. Eur J Cardiothorac Surg 47 : 567-572, 2015.
PubMed
17) Tateishi Y, et al : Postoperative Radiotherapy for Completely Resected Masaoka/Masaoka-Koga Stage II/III Thymoma Improves Overall Survival : An Updated Meta-Analysis of 4746 Patients. J Thorac Oncol 16 : 677-685, 2021.
PubMed
P.197 掲載の参考文献
1) Castleman B, et al : Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9 : 822-830, 1956.
PubMed
2) Fajgenbaum DC, et al : International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood 129 : 1646-1657, 2017.
PubMed
3) Masaki Y, et al : Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan. J Clin Exp Hematop 59 : 175-178, 2019.
PubMed
4) Ye B, et al : A retrospective study of unicentric and multicentric Castleman's disease : a report of 52 patients. Med Oncol 27 : 1171-1178, 2010.
PubMed
5) Talat N, et al : Surgery in Castleman's disease : a systematic review of 404 published cases. Ann Surg 255 : 677-684, 2012.
PubMed
6) Jiang JP, et al : A retrospective study of 34 patients with unicentric and multicentric Castleman's disease : Experience from a single institution. Oncol Lett 15 : 2407-2412, 2018.
PubMed
7) Yu L, et al : Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood 129 : 1658-1668, 2017.
PubMed
8) Frizzera G : Castleman's disease and related disorders. Semin Diagn Pathol 5 : 346-364, 1988.
PubMed
9) 森茂郎, ほか : 著しい多クローン性高免疫グロブリン血症と全身リンパ節の高度の形質細胞増生を呈する症候群-形質細胞型Castlemanリンパ腫との異同-. 日本網内系学会会誌 20 (Suppl) : 85-94, 1980.
 
10) van Rhee F, et al : International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood 132 : 2115-2124, 2018.
PubMed
11) Masaki Y, et al : 2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome. Int J Hematol 111 : 155-158, 2020.
PubMed
12) Suichi T, et al : Treatment response and prognosis of POEMS syndrome coexisting with Castleman disease. J Neurol Sci 413 : 116771, 2020.
PubMed
13) Sato Y, et al : IgG4-related disease : historical overview and pathology of hematological disorders. Pathol Int 60 : 247-258, 2010.
PubMed
14) Ozawa Y, et al : Two patients with TAFRO syndrome exhibiting strikingly similar anterior mediastinal lesions with predominantly fat attenuation on chest computed tomography. Respir Investig 55 : 176-180, 2017.
PubMed
P.202 掲載の参考文献
1) Hamman L : Spontaneous mediastinal emphysema. Bull Johns Hopkins Hosp 64 : 1-21, 1939.
 
2) Sahni S, et al : Spontaneous pneumomediastinum : time for consensus. N Am J Med Sci 5 : 460-464, 2013.
PubMed
3) Abolnik I, et al : Spontaneous pneumomediastinum. A report of 25 cases. Chest 100 : 93-95, 1991.
PubMed
4) Macklin CC : Transport of air along sheaths of pulmonic blood vessels from alveoli to mediastinum. Arch Intern Med 64 : 913-926, 1939.
 
5) Bakhos CT, et al : Spontaneous pneumomediastinum : an extensive workup is not required. J Am Coll Surg 219 : 713-717, 2014.
 
6) Macia I, et al : Spontaneous pneumomediastinum : 41 cases. Eur J Cardiothorac Surg 31 : 1110-1114, 2007.
PubMed
7) Takada K, et al : Management of spontaneous pneumomediastinum based on clinical experience of 25 cases. Respir Med 102 : 1329-1334, 2008.
PubMed
8) Panacek EA, et al : Spontaneous pneumomediastinum : clinical and natural history. Ann Emerg Med 21 : 1222-1227, 1992.
PubMed
9) Ebina M, et al : Management of spontaneous pneumomediastinum : Are hospitalization and prophylactic antibiotics needed? Am J Emerg Med 35 : 1150-1153, 2017.
PubMed
10) Koullias GJ, et al : Current assessment and management of spontaneous pneumomediastinum : experience in 24 adult patients. Eur J Cardiothorac Surg 25 : 852-855, 2004.
PubMed
11) Campillo-Soto A, et al : [Spontaneous pneumomediastinum : descriptive study of our experience with 36 cases]. Arch Bronconeumol 41 : 528-531, 2005.
PubMed
12) Caceres M, et al : Spontaneous pneumomediastinum : a comparative study and review of the literature, Ann Thorac Surg 86 : 962-966, 2008.
PubMed
13) Perna V, et al : Pneumomediastinum : is this really a benign entity? When it can be considered as spontaneous? Our experience in 47 adult patients. Eur J Cardiothorac Surg 37 : 573-575, 2010.
PubMed
P.208 掲載の参考文献
1) Demicco EG, et al : Solitary fibrous tumor. In : WHO Classification of Tumours, 5th ed, Vol 3, Soft Tissue and Bone Tumours (ed by WHO Classification of Tumours Editorial Board), p104-108, IARC Press, Lyon, 2020.
 
2) Robinson DR, et al : Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 45 : 180-185, 2013.
PubMed
3) Chmielecki J, et al : Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45 : 131-132, 2013.
PubMed
4) Demicco EG, et al : Solitary fibrous tumor : a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol 25 : 1298-1306, 2012.
PubMed
5) Demicco EG, et al : Risk assessment in solitary fibrous tumors : validation and refinement of a risk stratification model. Mod Pathol 30 : 1433-1442, 2017.
PubMed
6) Collini P, et al : High-grade sarcomatous overgrowth in solitary fibrous tumors : a clinicopathologic study of 10 cases. Am J Surg Pathol 36 : 1202-1215, 2012.
PubMed
7) Thway K, et al : Heterologous osteosarcomatous and rhabdomyosarcomatous elements in dedifferentiated solitary fibrous tumor : further support for the concept of dedifferentiation in solitary fibrous tumor. Ann Diagn Pathol 17 : 457-463, 2013.
PubMed
8) Kurisaki-Arakawa A, et al : A case of dedifferentiated solitary fibrous tumor in the pelvis with TP53 mutation. Virchows Arch 465 : 615-621, 2014.
PubMed
9) Schweizer L, et al : Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol 125 : 651-658, 2013.
PubMed
10) Doyle LA, et al : Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 27 : 390-395, 2014.
PubMed
11) Yoshida A, et al : STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol 38 : 552-559, 2014.
PubMed
12) BarthelmeB S, et al : Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 184 : 1209-1218, 2014.
PubMed
13) Yarnada Y, et al : Clinicopathological review of solitary fibrous tumors : dedifferentiation is a major cause of patient death. Virchows Arch 475 : 467-477, 2019.
 
14) Kohashi K et al : Reduced expression of SMARCB1/INI1 protein in synovial sarcoma. Mod Pathol 23 : 981-990, 2010.
PubMed
P.211 掲載の参考文献
1) O'Brien JE, Stout AP : Malignant fibrous xanthomas. Cancer 17 : 1445-1455, 1964.
PubMed
2) WHO Classification of Tumours, 4th ed, Vol 5, WHO Classification of Tumours of Soft Tissue and Bone (ed by Fletcher CDM, et al), p236-238, IARC Press, Lyon, 2013.
 
3) Weiss SW, Enzinger FM : Malignant fibrous histiocytoma : an analysis of 200 cases. Cancer 41 : 2250-2266, 1978.
PubMed
4) 堀米秀夫, ほか : 縦隔原発悪性線維性組織球腫の1例. 日本胸部臨床 56 : 777-781, 1997
 
5) Murakawa T, et al : Malignant fibrous histiocytoma in the anterior mediastinum. Jpn J Thorac Cardiovasc Surg 49 : 722-727, 2001.
PubMed
6) 中村純也, ほか : 若年者の縦隔原発未分化多形肉腫の1例. 日本呼吸器学会誌 8 : 2-5, 2019.
Medical*Online
7) 近藤大造, ほか : 縦隔原発悪性線維性組織球腫の一例. 外科診療 30 : 384-388, 1988.
 
8) Goh MH, et al : Anterior mediastinal masses : an anaesthetic challenge. Anaesthesia 54 : 670-674, 1999.
PubMed
9) 近藤和也 : 前縦隔巨大腫瘍に対する全身麻酔下の生検および根治手術の問題点. 日本臨床麻酔学会誌 23 : 280-283, 2003.
 
10) 鈴木昭広, ほか : 換気不全に陥った巨大縦隔腫瘍の麻酔経験. 麻酔と蘇生 33 : 33-35, 1997.
Medical*Online
11) Erdos G, Tzanova I : Perioperative anaesthetic management of mediastinal mass in adults. Eur J Anaesthesiol 26 : 627-632, 2009.
PubMed
12) Leite C, et al : Chemotherapy of malignant fibrous histiocytoma : a Southwest Oncology Group report. Cancer 40 : 2010-2014, 1977.
 
13) Fuchs R, et al : Results of ifosfamide combination chemotherapy in patients with advanced soft tissue sarcomas. Contr Oncol 26 : 153-158, 1987.
 
14) Urban C, et al : Chemotherapy of malignant fibrous histiocytoma of bone. A report of five cases. Cancer 51 : 795-802, 1983.
 
15) Bramwell V, et al ; Sarcoma Disease Site Group : Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. Cochrane Database Syst Rev 2003 (3) : CD003293, 2003.
PubMed
P.218 掲載の参考文献
1) Shennan T : Histologically non-malignant angioma, with numerous metastases. J Pathol Bacteriol 19 : 139-154, 1914.
 
2) Yamazaki A, et al : Cavernous Hemangioma of the Anterior Mediastinum : case report and 50-year review of Japanese cases. Jpn J Thorac Cardiovasc Surg 54 : 221-224, 2006.
PubMed
3) 篠原茉莉子, ほか : 完全胸腔鏡下にて摘出した左下葉無気肺を呈する巨大後縦隔血管腫. 肺癌 59 : 1151-1155, 2019.
Medical*Online
4) International Society for the Study of Vascular Anomalie : ISSVA classification for vascular anomalies(C) (Approved at the 20th ISSVA Workshop, Melbourne, April 2014, last revision May 2018) [https://www.issva.org/classification]
 
5) 「難治性血管腫・血管奇形・リンパ管腫・リンパ管腫症および関連疾患についての調査研究」班 : 血管腫・血管奇形・リンパ管奇形診療ガイドライン 2017 [第2版], 2017.
 
6) Okochi T, et al : Cavernous hemangioma in the mediastinum : A case report focusing on multimodal image findings. Jichi Medical University Journal (40) : 17-21, 2018.
 
7) Vikkula M, et al : Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87 : 1181-1190, 1996.
PubMed
8) Gross BA, et al : The natural history of intracranial cavernous malformations. Neurosurg Focus 30 : E24, 2011.
PubMed
9) McAdams HP, et al : Mediastinal hemangioma : radiographic and CT features in 14 patients. Radiology 193 : 399-402, 1994.
PubMed
10) Mazoyer E, et al : Coagulation Disorders in Patients With Venous Malformation of the Limbs and Trunk : a case series of 118 patients. Arch Dermatol 144 : 861-867, 2008.
 
11) Dompmartin A, et al : Association of Localized Intravascular Coagulopathy With Venous Malformations. Arch Dermatol 144 : 873-877, 2008.
PubMed
12) Nozaki T, et al : Syndromes associated with vascular tumors and malformations : a pictorial review. RadioGraphics 33 : 175-195, 2013.
PubMed
13) Goyal M, et al : Venous vascular malformations in pediatric patients : cornparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology 223 : 639-644, 2002.
PubMed
14) Sakurai K, et al : Thoracic hemangiomas : imaging via CT, MR, and PET along with pathologic correlation. J Thorac Imaging 23 : 114-120, 2008.
 
15) Vilgrain V, et al : Imaging of atypical hemangiomas of the liver with pathologic correlation. RadioGraphics 20 : 379-397, 2000.
PubMed
P.221 掲載の参考文献
1) 鮫島譲司, ほか : 気管支原性嚢胞の臨床病理学的検討. 日本呼吸器外科学会雑誌 24 : 784-788, 2010.
 
2) Limaiem F, et al : Pulmonary and mediastinal bronchogenic cysts : a clinicopathologic study of 33 cases. Lung 186 : 55-61, 2008.
PubMed
3) Kozu Y, et al : Single institutional experience with primary mediastinal cysts : clinicopathological study of 108 resected cases. Ann Thorac Cardiovasc Surg 20 : 365-369, 2014.
PubMed
4) St-Georges R, et al : Clinical spectrum of bronchogenic cysts of the mediastinum and lung in the adult. Ann Thorac Surg 52 : 6-13, 1991.
PubMed
5) 三浦弘之, ほか : 発生部位からみた気管支嚢胞手術例の検討. 日本臨床外科学会雑誌 62 : 1813-1818, 2001.
 
6) Kawaguchi M, et al : CT and MRI characteristics for differentiating mediastinal Mullerian cysts from bronchogenic cysts. Clin Radiol 74 : 976.e19-976.e25, 2019.
 
7) Lu Q, et al : Spontaneous rupture of a giant intrapericardial bronchogenic cyst. Ann Thorac Surg 96 : e109-110, 2013.
PubMed
8) McAdams HP, et al : Bronchogenic cyst : imaging features with clinical and histopathologic correlation. Radiology 217 : 441-446, 2000.
PubMed
9) Kirmani B, et al : Should asymptomatic bronchogenic cysts in adults be treated conservatively or with surgery? Interact Cardiovasc Thorac Surg 11 : 649-659, 2010.
PubMed
P.225 掲載の参考文献
1) 浅野久敏, ほか : 完全胸腔鏡下手術による巨大成熟型嚢胞性奇形腫の一切除例. 日本呼吸器外科学会雑誌 25 : 522-526, 2011.
 
2) 佐藤伸之 : 奇形腫群腫瘍. 呼吸器腫瘍外科学 (藤村重文編), p295-300, 南江堂, 1999.
 
3) 吉武毅 : 縦隔胚細胞腫瘍. 胸部外科 43 : 582-591, 1990.
 
4) 堀内翔, ほか : 成熟型縦隔奇形腫左胸腔内穿破の1切除例. 日本呼吸器外科学会雑誌 31 : 784-788, 2017.
 
5) Bradford ML, et al : Mediastinal cysts and tumors. Surg Gynecol Obstet 85 : 467-491, 1947.
PubMed
6) Sasaka K, et al : Spontaneous rupture : A complication of benign mature teratomas of the mediastinum. AJR Am J Roentgenol 170 : 323-328, 1998.
PubMed
7) 生井克美, ほか : 縦隔Teratoid tumorの2例. その破裂に関する考察. 胸部外科 11 : 880-884, 1958.
 
8) 山口智之, ほか : 膵組織成分が誘因と考えられた喀血を伴う成熟型縦隔奇形腫の1例. 日本臨床外科学会雑誌 79 : 495-499, 2018.
 
9) 村田尚彦, ほか : 肺膿瘍及び肺癌との鑑別が困難であった縦隔奇形腫の1例. 日本胸部疾患学会雑誌 30 : 328-332, 1992,
 
10) De Backer A, et al : Influence of tumor site and histology on long-term survival in 193 children with extracranial germ cell tumors. Eur J Pediatr Surg 18 : 1-6, 2008.
PubMed
11) Hiroshima K, et al : Apoptosis and proliferative activity in mature and immature teratomas of the mediastinum. Cancer 92 : 1798-1806, 2001.
PubMed
12) 日野佑美, ほか : 血中CA19-9が高値を示した前縦隔未熟奇形腫の1手術例. 日本呼吸器外科学会雑誌 26 : 602-608, 2012.
 
13) Wick MR et al : Germ cell tumours with somatic-type malignancy. In : WHO Classification of Tumours, 3rd ed, Vol 10, Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (ed by Travis WD, et al), p216-218, IARC Press, Lyon, 2004.
 
14) 管野隆三, ほか : AFP, CA19-9, CA12-5が高値を示した縦隔未熟奇形腫の1例. 日本呼吸器外科学会雑誌 8 : 629-637, 1994.
 
15) 鈴木秀一, ほか : G-CSFを産生し, 腺癌への悪性転化を伴った縦隔奇形腫の1例. 肺癌 46 : 79-81, 2006.
 
P.228 掲載の参考文献
1) Rosai and Ackerman's Surgical Pathology, 11th ed (ed by Goldblum JR, et al), p1850-1851, Elsevier, Philadelphia, 2018.
 
2) Lin JJ, et al : Two entities in angiolipoma. A study of 459 cases of lipoma with review of literature on infiltrating angioliporna. Cancer 34 : 720-727, 1974.
PubMed
3) Liu P, et al : A giant infiltrating angiolipoma of the mediastinum : a case report. J Cardiothorac Surg 11 : 164, 2016.
 
4) Kline ME, et al : Noninfiltrating angiolipoma of the mediastinum. Radiology 175 : 737-738, 1990.
PubMed
5) Gorospe L, et al : Preoperative Embolization of a Posterior Mediastinal Lipid-Poor Angiolipoma Mimicking a Paravertebral Nerve Sheath Tumor. Ann Thorac Surg 100 : 705-707, 2015.
PubMed
6) Negri G, et al : Mediastinal dumbbell angiolipoma. Ann Thorac Surg 70 : 957-958, 2000.
PubMed
7) Choi JY, et al : Angiolipoma of the posterior mediastinum with extension into the spinal canal : a case report. Korean J Radiol 1 : 212-214, 2000.
PubMed
8) Gamez Garcia P, et al : [Mediastinal dumbbell angiolipoma]. Arch Bronconeumol 38 : 545-546, 2002.
PubMed
9) Gelabert-Gonzalez M, et al : Spinal extradural angiolipoma, with a literature review. Childs Nerv Syst 18 : 725-728, 2002.
PubMed
10) Rodrigues JCL, et al : A rare cause of neural foraminal widening. J Radiol Case Rep 6 : 1-8, 2012.
PubMed
11) Nakamura D, et al : Primary posterior mediastinal angiolipoma : a case report. J Surg Case Rep 2021 : rjab168, 2021.
PubMed
12) 藤生浩一, ほか : Dumbbell型を呈した後縦隔血管脂肪腫の1例. 日本呼吸器外科学会雑誌 13 : 844-849, 1999.
 
13) 赤沢慶子, ほか : 左胸水を合併した縦隔血管脂肪腫の1例. 日本呼吸器学会誌 5 : 312-315, 2016.
Medical*Online
14) Labram EK, et al : Revisited : spinal angiolipoma-three additional cases. Br J Neurosurg 13 : 25-29, 1999.
PubMed
15) Gelabert-Gonzalez M, Garcia-Allut A : Spinal extradural angiolipoma : report of two cases and review of the literature. Eur Spine J 18 : 324-335, 2009.
PubMed
P.230 掲載の参考文献
1) Weidner N : Germ-cell tumors of the mediastinum. Semin Diagn Pathol 16 : 42-50, 1999.
PubMed
2) Temes R, et al : Primary mediastinal malignancies : findings in 219 patients. West J Med 170 : 161-166, 1999.
PubMed
3) 吉竹毅 : 縦隔原発胚細胞性腫瘍. 胸部外科 43 : 582-592, 1990.
 
4) 古賀智子, ほか : 術直後に多発肺転移を来した高齢者縦隔原発絨毛癌の一例. 日本呼吸器外科学会雑誌 33 : 560-565, 2019.
 
5) Prusty S, et al : Primary mediastinal choriocarcinoma. Dis Chest 56 : 543-546, 1969.
PubMed
6) Wenger ME, et al : Primary mediastinal choriocarcinoma. Mayo Clin Proc 43 : 570-575, 1968.
PubMed
7) Bokemeyer C, et al : Extragonadal germ cell tumors of the mediastinum and retroperitoneum : results from an international analysis. J Clin Oncol 20 : 1864-1873, 2002.
PubMed
8) 精巣腫瘍診療ガイドライン [2015年版] (日本泌尿器科学会編), 金原出版, 2015.
 
9) Culine S, et al : Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate-and poor-risk metastatic nonseminomatous germ cell tumors : Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP. J Clin Oncol 26 : 421-427, 2008.
PubMed
P.233 掲載の参考文献
1) 正岡昭 : 神経原性腫瘍neurogenic tumor. 呼吸器外科学 [第4版] (正岡昭監, 藤井義敬編), p412-415, 南山堂, 2009.
 
2) Gangadharan SP : Neurogenic tumors of the posterior mediastinum. In Adult Chest Surgery, 2nd ed (ed by Sugarbaker DJ, et al), p1287-1295, MacGraw-Hill Education, New York, 2014.
 
3) Shields TW : Benign and malignant neurogenic tumors of the mediastinum in adults. In : General Thoracic Surgery, 5th ed (ed by Shields TW, et al), p2313-2327, Lippincott Williams & Wilkins, Philadelphia, 200Q
 
4) Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, et al : Thoracic and cardiovascular surgeries in Japan during 2017 : Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 68 : 414-449, 2020.
PubMed
5) Reynolds M, Shields TW : Benign and malignant mediastinal neurogenic tumors in infant and children. In : General Thoracic Surgery, 5th ed (ed by Shields TW, et al), p2301-2312, Lippincott Williams & Wilkins, Philadelphia, 2000.
 
6) Kawaguchi T, et al : Primary intrathoracic malignant neurogenic tumor : report of three cases and comparison with benign neurogenic tumors resected at our institution. Surg Case Rep 1 : 6, 2015.
PubMed
7) Chen X, et al : Surgical treatment of posterior mediastinal neurogenic tumors. J Surg Oncol 119 : 807-813, 2019.
PubMed
8) Lacquet M, et al : Surgery for mediastinal neurogenic tumours : a25-year single-centre retrospective study. Interact Cardiovasc Thorac Surg 32 : 737-743, 2021.
 
9) Fujimoto K, et al : Proposal for a new mediastinal compartment classification of transverse plane images according to the Japanese Association for Research on the Thymus (JART) General Rules for the Study of Mediastinal Tumors. Oncol Rep 31 : 565-572, 2014.
 
10) 中園貴彦, ほか : 神経原性腫瘍. 画像診断 37 : 1187-1196, 2017.
Medical*Online
11) Ozawa Y, et al : Imaging findings of lesions in the middle and posterior mediastinum. Jpn J Radiol 39 : 15-31, 2021.
PubMed
12) Broski SM, et al : Evaluation of 18F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors. Skeletal Radiol 45 : 1097-1105, 2016.
PubMed
13) 境澤隆夫, ほか : FDG-PETで高集積を示した肺内神経鞘腫の1例. 日本呼吸器外科学会雑誌 33 : 538-543, 2019.
 
14) Li XK et al : Clinical efficacy of robot-assisted thoracoscopic surgery for posterior mediastinal neurogenic tumors. J Thorac Dis 12 : 3065-3072, 2020.
PubMed
15) Nishida Y, et al : Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors. Int J Cancer 148 : 140-149, 2021.
 
P.238 掲載の参考文献
1) 精巣腫瘍取扱い規約 [第4版] (日本泌尿器科学会, ほか編), 金原出版, 2018.
 
2) 精巣腫瘍診療ガイドライン [2015年版] (日本泌尿器科学会編), 金原出版, 2015.
 
3) Bokemeyer C, et al : Extragonadal germ cell tumors of the mediastinum and retroperitoneum : results from an international analysis. J Clin Oncol 20 : 1864-1873, 2002.
PubMed
4) Sheikine Y, et al : Molecular genetics of testicular germ cell tumors. Am J Cancer Res 2 : 153-167, 2012.
PubMed
5) International Germ Cell Consensus Classification : a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15 : 594-603, 1997.
 
6) Howell SJ, Sharet SM : Testicular function following chemotherapy. Hum Reprod Update 7 : 363-369, 2001.
 
7) Gospodarowicz M : Testicular cancer patients : considerations in long-term follow-up. Hematol Oncol Clin North Am 22 : 245-255, vi, 2008.
PubMed
8) Hartmann JT, Fossa SD, et al : Extragonadal seminoma : an international multicenter analysis of prognostic factors and long term treatment outcome. Cancer 91 : 1394-1401, 2001.
PubMed
9) Koizumi T, et al : Primary mediastinal germ cell tumors-A retrospective analysis of > 30 years of experience in a single institution. Thorac Cancer 12 : 807-813, 2021.
 
P.242 掲載の参考文献
1) Katlic MR, et al : Substernal goiter. Ann Thorac Surg 39 : 391-399, 1985.
PubMed
2) Mack E : Management of patients with substernal goiters. Surg Clin North Am 75 : 377-394, 1995.
PubMed
3) McCort JJ : Intrathoracic goiter ; its incidence, symptomatology, and roentgen diagnosis. Radiology 53 : 227-237, 1949.
PubMed
4) Foroulis CN, et al : Primary intrathoracic goiter : a rare and potentially serious entity. Thyroid 19 : 213-218, 2009.
 
5) Nakaya M, et al : Surgical treatment of substernal goiter : An analysis of 44 cases. Auris Nasus Larynx 44 : 111-115, 2017.
PubMed
6) 岡本啓希, ほか : 胸腔縦隔鏡と頸部アプローチ併用にて摘出し得た前縦隔甲状腺腫例. 耳鼻咽喉科臨床 113 : 519-524, 2020.
 
P.246 掲載の参考文献
1) Sceusi E, Vaporciyan AA : Benign and Malignant Neurogenic Tumors of the Mediastinum in Children and Adults. In : Shields'General Thoracic Surgery, 8th ed (ed by LoCicero J 3rd, et al), p2194-2225, Wolters Kluwer, Philadelphia, 2019.
 
2) Takeda S, et al : Intrathoracic neurogenic tumors-50 years' experience in a Japanese institution. Eur J Cardiothorac Surg 26 : 807-812, 2004.
 
3) Duwe BV, et al : Tumors of the mediastinum. Chest 128 : 2893-2909, 2005.
PubMed
4) Sakata R, et al : Thoracic and cardiovascular surgery in Japan during 2008 : annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 58 : 356-383, 2010.
PubMed
5) Bourgouin PM, et al : Plexiform neurofibromatosis of the mediastinum : CT appearance. AJR Am J Roentgenol 151 : 461-463, 1988.
PubMed
6) Kresak JL, Walsh M : Neurofibromatosis : A Review of NF1, NF2, and Schwannomatosis. J Pediatr Genet 5 : 98-104, 2016.
PubMed
7) Hayashi K, et al : Adjacent schwannomas originating from intercostal and sympathetic nerves. BMJ Case Rep 2018 : bcr2018225970, 2018.
PubMed
8) Jokinen CH, et al : Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms. Am J Clin Pathol 129 : 886-893, 2008.
PubMed
9) Occhipinti M, et al : Imaging the posterior mediastinum : a multimodality approach. Diagn Interv Radiol 21 : 293-306, 2015.
PubMed
10) Sakai F, et al : Intrathoracic neurogenic tumors : MR-pathologic correlation. AJR Am J Roentgenol 159 : 279-283, 1992.
PubMed
11) Beaulieu S, et al : Positron emission tomography of schwannomas : emphasizing its potential in preoperative planning. AJR Am J Roentgenol 182 : 971-974, 2004.
PubMed
12) Venissac N, et al : Mediastinal neurogenic tumors and video-assisted thoracoscopy : always the right choice? Surg Laparosc Endosc Percutan Tech 14 : 20-22, 2004.
PubMed
13) Al-Mufarrej F, et al : Novel thoracoscopic approach to difficult posterior mediastinal tumors. Gen Thorac Cardiovasc Surg 58 : 636-639, 2010.
PubMed
14) Ruurda JP, et al : Robot-assisted thoracoscopic resection of a benign mediastinal neurogenic tumor : technical note. Neurosurgery 52 : 462-464 ; discussion 464, 2003.
PubMed
15) Eden K : The dumb-bell tumors of the spine. Br J Surg 28 : 549-570, 1941.
 
P.249 掲載の参考文献
1) Chen H, et al : The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors : pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39 : 775-783, 2010.
PubMed
2) 片山達也, ほか : 前縦隔に発生したpigmented paraganglioma. 胸部外科 72 : 108-111, 2019.
 
3) 藤原俊哉, ほか : 後縦隔に発生した非機能性巨大傍神経節腫の1切除例. 日本呼吸器外科学会雑誌 28 : 188-192, 2014.
 
4) Welander J, et al : Genetics and clinical characteristics of hereditary Pheochromocytomas and paragangliomas. Endocr Relat Cancer 18 : R253-276, 2011.
PubMed
5) 日野春秋, ほか : 後縦隔原発の傍神経節細胞腫の1切除例. 日本呼吸器外科学会雑誌 25 : 657-661, 2011.
 
6) Prades CA, et al : Metastatic Malignant Paraganglioma : A Case Report and Review of Literature. World J Oncol 8 : 92-95, 2017.
PubMed
7) Moran CA, et al : Pigmented extraadrenal paragangliomas. A clinicopathologic and immunohistochemical study of five cases. Cancer 79 : 398-402, 1997.
PubMed
8) Kim SH, et al : Pigmented Mediastinal Paraganglioma : A case report. Korean J Pathol 34 : 597-600, 2000.
 
9) 宮田佐門, ほか : 大動脈弓下パラガングリオーマの1例-その画像診断を中心に-. 肺癌 32 : 559-564, 1992.
 
10) Brown ML, et al : Mediastinal Paragangliomas : The Mayo Clinic Experience. Ann Thorac Surg 86 : 946-951, 2008.
 
11) 足立孝, ほか : 集学的治療を行った縦隔原発paragangliomaの1例. 日本呼吸器外科学会雑誌 16 : 779-783, 2002.
 
12) Kimura S, et al : Combination chemotherapy for malignant paraganglioma. Intern Med 36 : 35-39, 1997.
PubMed
13) Averbuch SD, et al : Malignant pheochromocytoma : effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 109 : 267-273, 1988.
PubMed
14) 臨床・病理 縦隔腫瘍取扱い規約 [第1版] (日本胸腺研究会編), 金原出版, 2009.
 
15) Lamy AL, et al : Anterior and middle mediastinum paraganglioma : complete resection is the treatment of choice. Ann Thorac Surg 57 : 249-252, 1994.
PubMed
P.253 掲載の参考文献
1) Parish JM, et al : Mediastinal granuloma and mediastinal fibrosis. Semin Respir Crit Care Med 23 : 135-143, 2002.
PubMed
2) 鈴木隆ほか : 縦隔肉芽腫 : 縦隔疾患. 縦隔腫瘍. 別冊日本臨牀新領域別症候群シリーズ No. 10 呼吸器症候群 (第2版) III, p496-498, 日本臨牀社, 2009.
 
3) Schowengerdt CG, et al : Granulomatous and fibrous mediastinitis. A review and analysis of 180 cases. J Thorac Cardiovasc Surg 57 : 365-379, 1969.
 
4) Santos LM, et al : The role of endobronchial ultrasound-guided transbronchial needle aspiration in isolated intrathoracic lymphadenopathy in non-neoplastic patients : a common dilemma in clinical practice. J Bras Pneumol 46 : e20180183, 2020.
PubMed
5) Narula N, Iannuzzi M : Sarcoidosis : Pitfalls and Challenging Mimickers. Front Med (Lausanne) 7 : 594275, 2021.
PubMed
6) Vawda F, et al : Massive cryptococcal lymphadenopathy in an immunocompetent pregnant patient. Br J Radiol 81 : e53-56, 2008.
 
7) Muller NL, Silva CIS : Sarcoidosis. In : Imaging of the Chest, Vol 1 (ed by Muller NL, Silva CIS), p668-688, WB Saunders, Philadelphia, 2008.
 
8) Berger J, et al : Usefulness of lymphoid granulomatous inflammation culture obtained by endobronchial uitrasound-guided transbronchial needle aspiration in a fungal endemic area. Endosc Ultrasound 5 : 243-247, 2016.
 
9) Goodwin RA, et al : Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) 51 : 227-246, 1972.
PubMed
10) Kobayashi Y, et al : Clinical Features of Fibrosing Mediastinitis in Japanese Patients : Two Case Reports and a Literature Review. Intern Med, 2021. (DOI : 10.2169/internalmedicine.5737-20)
 
11) Stone JH, et al : IgG4-related disease. N Engl J Med 366 : 539-551, 2012.
PubMed
12) 野村基子, ほか : 血清IgG4高値と限局性肉芽腫性血管炎を合併し診断に苦慮した炎症性縦隔腫瘤の1例. 日本呼吸器学会誌 5 : 23-27, 2016.
Medical*Online
13) Noh D, et al : Immunoglobulin G4-related sclerosing disease invading the trachea and superior vena cava in mediastinum. Eur J Cardiothorac Surg 45 : 573-575, 2014.
PubMed
P.257 掲載の参考文献
1) 原眞咲, ほか : 臨床・病理 縦隔腫瘍取扱い規約 [第1版] (日本胸腺研究会編)，金原出版, 2009.
 
2) Jeung MY, et al : Imaging of cystic masses of the mediastinum, Radiographics 22 : S79-93, 2002.
PubMed
3) 藪内英剛, ほか : 縦隔区分と機能画像による縦隔腫瘍の鑑別診断. 臨床放射線 62 : 29-51, 2017.
 
4) Zambudio AR, et al : Non-neoplastic mediastinal cysts. Eur J Cardiothorac Surg 22 : 712-716, 2002.
PubMed
5) Harvell JD, et al : Isolated intra-abdominal esophageal cyst. Case report and review of the literature. Am J Surg Pathol 20 : 476-479, 1996.
PubMed
6) Tabotta F, et al : Imaging features and differential diagnoses of non-neoplastic diffuse mediastinal diseases. Insights Imaging 11 : 111, 2020.
PubMed
7) 野中誠, 門倉光隆 : 降下性壊死性縦隔炎 : 早期発見と適正な治療のために. 日本集中治療医学会雑誌 15 : 41-48, 2008.
 
8) 岩本圭亮, ほか : 後縦隔Muller管嚢胞の1例. 日本臨床外科学会雑誌 77 : 1917-1922, 2016.
 
9) Hattori H : Ciliated cyst of probablc mullerian origin arising in the posterior mediastinum. Virchows Arch 446 : 82-84, 2005.
PubMed
P.260 掲載の参考文献
1) Bokemeyer C, et al : Extragonadal germ cell tumors of the mediastinum and retroperitoneum : results from an international analysis. J Clin Oncol 20 : 1864-1873, 2002.
PubMed
2) Colnmittee for Scientific Affairs, The Japanese Association for Thoracic Surgery, et al : Thoracic and cardiovascular surgeries in Japan during 2017 : Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 68 : 414-449, 2020.
PubMed
2) Barrand KG, Freeman NV : Massive infiltrating cystic hygroma of the neck in infancy. Arch Dis Child 48 : 523-531, 1973.
PubMed
3) Moran CA, et al : Primary germ cell tumors of the mediastinum : I. Analysis of 322 cases with special emphasis on teratomatous lesions and a proposal for histopathologic classification and clinical staging. Cancer 80 : 681-690, 1997.
 
3) 阿部良行, ほか : 縦隔リンパ管腫の1例. 胸部外科 41 : 1085-1089, 1988.
 
4) Takeda S, et al : Primary germ cell tumors in the mediastinum : a 50-year experience at a single Japanese institution. Cancer 97 : 367-376, 2003.
 
4) 厚生労働科学研究費補助金難治性疾患等政策研究事業 (難治性疾患政策研究事業) 難治性血管腫・脈管奇形・血管奇形・リンパ管腫・リンパ管腫症および関連疾患についての調査研究, 三村班疫学調査, 2014.
 
5) Hakiri S, et al : Verification of the diagnostic strategy for anterior mediastinal tumors. Int J Clin Oncol 24 : 385-393, 2019.
PubMed
5) Shenoy SS, et al : Mediastinal lymphangioma. J Surg Oncol 10 : 523-528, 1978.
PubMed
6) Ueno S, et al : Treatment of mediastinal lymphatic malformation in children : an analysis of a nationwide survey in Japan. Surg Today 48 : 716-725, 2018.
PubMed
6) Moeller KH, et al : Mediastinal mature teratoma : imaging features. AJR Am J Roentgenol 169 : 985-990, 1997.
PubMed
7) Nakazato Y, et al : Cystic lymphangioma of the mediastinum. Am Heart J 129 : 406-409, 1995.
PubMed
7) Lee KS, et al : Malignant primary germ cell tumors of the mediastinum : CT features. AJR Am J Roentgenol 153 : 947-951, 1989.
PubMed
8) Drevelegas A, et al : Mediastinal germ cell tumors : a radiologic-pathologic review. Eur Radiol 11 : 1925-1932, 2001.
PubMed
8) 福原研一朗, ほか : 成人縦隔内嚢状リンパ管腫の1手術例. 日本呼吸器外科学会雑誌 12 : 805-809, 1998.
 
9) 荻田修平 : リンパ管腫の治療-特に硬化療法-. 小児外科 34 : 125-131, 2002.
 
9) Bokemeyer C, et al : Extragonadal seminoma : an international multicenter analysis of prognostic factors and long term treatment outcome. Cancer 91 : 1394-1401. 2001.
PubMed
10) Puc HS, et al : Management of residual mass in advanced seminoma : results and recommendations from the Memorial Sloan-Kettering Cancer Center. J Clin Oncol 14 : 454-460, 1996.
 
10) Ogita S, et al : OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 29 : 784-785, 1994,
PubMed
11) Culine S, et al : Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate-and poor-risk metastatic nonseminomatous germ cell tumors : Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP. J Clin Oncol 26 : 421-427, 2008.
PubMed
11) 「難治性血管腫・血管奇形・リンパ管腫・リンパ管腫症および関連疾患についての調査研究」班 : 平成26-28年度厚生労働科学研究費補助金難治性疾患等政策研究事業 (難治性疾患政策研究事業), 血管腫・血管奇形・リンパ管奇形診療ガイドライン 2017 [第2版], p157-160, 2017.
 
12) Hashizume N, et al : Clinical Efficacy of Herbal Medicine for Pediatric Lymphatic Malformationg. : A Pilot Study. Pediatr Dermatol 33 : 191-195, 2016.
PubMed
12) De Wit R, et al : Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma : a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer. Br J Cancer 78 : 828-832, 1998.
 
13) Hinton S, et al : Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors : final analysis of an intergroup trial. Cancer 97 : 1869-1875, 2003.
PubMed
14) Hartmann JT, et al : Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors. Ann Oncol 13 : 1017-1028, 2002.
PubMed
15) Kesler KA, et al : The "growing teratoma syndrome" in primary mediastinal nonseminomatous germ cell tumors : criteria based on current practice. J Thorac Cardiovasc Surg 144 : 438-443. 2012.
PubMed
P.264 掲載の参考文献
1) ISSVA classification for vascular anomalies : Approved at the 20th ISSVA Workshop, Melbourne, April 2014. [https://www.issva.org/UserFiles/file/Classifications-2014-Final.pdf]
 
P.268 掲載の参考文献
1) Cappelli C, et al : Prevalence of parathyroid cysts by neck ultrasound scan in unselected patients. J Endocrinol Invest 32 : 357-359, 2009.
PubMed
2) Moran CA, et al : Primary germ cell tumors of the mediastinum : III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum-a clinicopathologic and immunohistochemical study of 64 cases. Cancer 80 : 699-707, 1997.
PubMed
2) Ihm PS, et al : Parathyroid cysts : diagnosis and management. Laryngoscope 111 : 1576-1578, 2001.
PubMed
3) De Quervain F : Epithel-Korperchen-Cysti. Schweiz Med Wochenschr 55 : 1169, 1925.
 
3) Schlumberger HG : Teratoma of the anterior mediastinum in the group of military age ; a study of 16 cases and a review of theories of genesis. Arch pathol (Chic) 41 : 398-444, 1946.
 
4) Papavramidis TS, et al : Parathyroid cysts : A review of 359 patients reported in the international literature. Medicine (Baltimore) 97 : e11399, 2018.
PubMed
4) Moran CA : Germ cell tumors of the mediastinum. Pathol Res Pract 195 : 583-587, 1999.
PubMed
5) Shields TW, Immerman SC : Mediastinal parathyroid cysts revisited. Ann Thorac Surg 67 : 581-590, 1999.
PubMed
5) Norgaard-Pedersen B, et al : Serum alpha-foetoprotein as a marker for endodermal sinus tumour (yolk sac tumour) or a vitelline component of "teratocarcinoma". Acta Pathol Microbiol Scand A 83 : 573-589, 1975.
 
6) 小林哲, ほか : 頸部アプローチで切除し得た縦隔副甲状腺嚢腫の1例 : 文献報告133例の検討. 日本呼吸器外科学会雑誌 24 : 1041-1045, 2010.
 
6) 井上匡美 : 縦隔の胚細胞性腫瘍の治療コンセンサス癌治療 14 : 154-156, 2016.
 
7) Zhang XU, et al : Giant non-functional parathyroid cyst : A case report. Oncol Lett 11 : 2237-2240, 2016.
PubMed
7) Sakurai H, et al : Management of primary malignant germ cell tumor of the mediastinum. Jpn J Clin Oncol 34 : 386-392, 2004.
PubMed
8) Hainsworth JD, Greco FA : Nonseminomatous malignant germ cell tumors of the mediastinum. In : General Thoracic Surgery, 7th ed (ed by Shields TW, et al), p2403-2409, Lippincott Williams & Wilkins, Philadelphia, 2009.
 
8) Kawashima ST, et al : Primary hyperparathyroidism due to atypical vertically long cystic adenoma. Endocrinol Diabetes Metab Case Rep 2014 : 140086, 2014.
PubMed
9) Uchida N. et al : A case report of a functioning mediastinal parathyroid cyst with no 99mTc-MIBI uptake. Int J Surg Open 12 : 5-8, 2018.
 
9) Oechsle K, et al : [18F] Fluorodeoxyglucose Positron Emission Tomography in Nonseminomatous Germ Cell Tumors After Chemotherapy : The German Multicenter Positron Emission Tomography Study Group. J Clin Oncol 26 : 5930-5935, 2008.
 
10) Sakaguchi M, et al : Successful radiotherapy in postoperative recurrence of a primary mediastinal yolk sac tumor : A case report. Thorac Cancer 7 : 358-362, 2016.
PubMed
10) Wei CH, Harari A : Parathyroid carcinoma : update and guidelines for management. Curr Treat Options Oncol 13 : 11-23, 2012.
PubMed
11) Fortson JK, et al : Parathyroid cysts : a case report and review of the literature. Laryngoscope 111 : 1726-1728, 2001.
PubMed
12) 上林孝豊, ほか : 頸部切開に縦隔鏡を併用して摘出した縦隔内副甲状腺嚢腫の一例. 日本呼吸器外科学会雑誌 18 : 145-148, 2004.
 
13) El-Housseini Y, et al : Unusual presentations of functional parathyroid cysts : a case series and review of the literature. J Med Case Rep 11 : 333, 2017.
PubMed
14) Nafisi Moghadam R, et al : Comparative Diagnostic Performance of Ultrasonography and 99mTc-Sestamibi Scintigraphy for Parathyroid Adenoma in Primary Hyperparathyroidism : Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev 18 : 3195-3200, 2017.
PubMed
15) Pontikides N, et al : Diagnostic and therapeutic review of cystic parathyroid lesions. Hormones (Athens) 11 : 410-418, 2012.
PubMed
P.272 掲載の参考文献
1) Teilum G : Endodermal sinus tumors of the ovary and testis. Comparative morphogenesis of the so-called mesoephroma ovarii (Schiller) and extraembryonic (yolk sac-allantoic) structures of the rat's placenta. Cancer 12 : 1092-1105, 1959.
 
P.276 掲載の参考文献
1) Swerdlow SH, et al : The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127 : 2375-2390, 2016.
PubMed
2) Sarkozy C, et al : Mutational landscape of gray zone lymphoma. Blood 137 : 1765-1776, 2021.
PubMed
3) Weniger MA, et al : Human CD30+B cells represent a unique subset related to Hodgkin lymphoma cells. J Clin Invest 128 : 2996-3007, 2018.
 
4) Aoki T, Steidl C : Novel Biomarker Approaches in Classic Hodgkin Lymphoma. Cancer J 24 : 206-214, 2018.
PubMed
5) Gunawardana J, et al : Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma. Nat Genet 46 : 329-335, 2014
PubMed
6) Steidl C, et al : MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471 : 377-381, 2011.
PubMed
7) Roemer MG, et al : PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. J Clin Oncol 34 : 2690-2697, 2016.
PubMed
8) Mottok A, et al : Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens. Blood 132 : 2401-2405, 2018.
 
9) Steidl C, et al : Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 362 : 875-885, 2010.
PubMed
10) Eberle FC, et al : Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica 96 : 558-566, 2011.
 
11) Savage KJ, et al : The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102 : 3871-3879, 2003.
 
12) Dunleavy K, et al : Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med 368 : 1408-1416, 2013.
PubMed
13) Shah NN, et al : R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma : a multi-centre analysis. Br J Haematol 180 : 534-544, 2018.
PubMed
14) Malenda A, et al : Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma. Eur J Haematol 104 : 59-66, 2020.
PubMed
15) Aoki T, et al : High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma. Blood Cancer J 5 : e372, 2015.
 
16) Zinzani PL, et al : Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma : results from a phase 2 clinical trial. Blood 129 : 2328-2330, 2017.
 
17) Johnson P, McKenzie H : How I treat advanced classical Hodgkin lymphoma. Blood 125 : 1717-1723, 2015.
 
18) Crump M, et al : Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma. Blood 125 : 1708-1716, 2015.
PubMed
19) Townsend W, Linch D : Hodgkin's lymphoma in adults. Lancet 380 : 836-847, 2012.
PubMed
20) Ogura M, et al : Phase I/II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma. Cancer Sci 105 : 840-846. 2014.
 
21) Younes A, et al : Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. J Clin Oncol 30 : 2183-2189, 2012.
 
22) Connors JM, et al : Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma. N Engl J Med 378 : 331-344, 2018.
 
23) Schmitz N, et al : Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease : a randomised trial. Lancet 359 : 2065-2071. 2002.
PubMed
24) Sarina B, et al : Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation : a retrospective study based on the time of HLA typing and donor availability. Blood 115 : 3671-3677, 2010.
PubMed
25) Chen R, et al : Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma. Blood 128 : 1562-1566, 2016.
PubMed
26) Aoki T, et al : Biology in Practice : Harnessing the Curative Potential of the Immune System in Lymphoid Cancers. J Clin Oncol 39 : 346-360, 2021.
PubMed
27) Sarkozy C, et al : Mediastinal gray zone lymphoma : clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association. Haematologica 102 : 150-159, 2017.
PubMed
P.282 掲載の参考文献
1) Stein H, et al : Hodgkin lymphomas : Introduction. In : WHO Classification of Tumours, revised 4th ed, Vol 2, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed by Swerdlow SH, et al), p424-430, IARC Press, Lyon, 2017.
 
2) Mottok A, Steidl C : Biology of classical Hodgkin lymphoma : implications for prognosis and novel therapies. Blood 131 : 1654-1665, 2018.
PubMed
3) Sarkozy C, et al : Mutational landscape of gray zone lymphoma. Blood 137 : 1765-1776, 2021.
PubMed
4) Canellos GP, et al : Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327 : 1478-1484, 1992.
 
5) Connors JM, et al : Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma. N Engl J Med 378 : 331-344, 2018.
 
6) Merli F, et al : Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma : A Study by Fondazione Italiana Linfomi. J Clin Oncol 34 : 1175-1181, 2016.
PubMed
7) Press OW, et al : US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging : Southwest Oncology Group SO816. J Clin Oncol 34 : 2020-2027, 2016.
 
8) Johnson P, et al : Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. N Engl J Med 374 : 2419-2429, 2016.
PubMed
9) Sasse S, et al : Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma : Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials. J Clin Oncol 35 : 1999-2007, 2017.
 
10) Schmitz N, et al : Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease : a randomised trial. Lancet 359 : 2065-2071, 2002.
PubMed
11) Younes A, et al : Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. J Clin Oncol 30 : 2183-2189, 2012.
 
12) Armand P, et al : Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation : Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial. J Clin Oncol 36 : 1428-1439, 2018.
 
13) Chen R, et al : Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma. J Clin Oncol 35 : 2125-2132, 2017.
PubMed
14) Kuruvilla J, et al : Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204) : an interim analysis of a multicentre, randomised, open-label, phase 3 study. Lancet Oncol 22 : 512-524, 2021.
PubMed
15) Merryman RW, et al : Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma. Leukemia 35 : 2672-2683, 2021.
PubMed
P.288 掲載の参考文献
1) 叶宗一郎, 小林英夫 : 縦隔リンパ節炎 ; 縦隔疾患. 縦隔腫瘍. 別冊日本臨牀新領域別症候群シリーズ No. 10 呼吸器症候群 (第2版) III, p521-524, 日本臨牀社, 2009.
 
2) Nin CS, et al : Thoracic lymphadenopathy in benign diseases : A state of the art review. Respir Med 112 : 10-17, 2016.
 
3) 尾形英雄, 岩井和郎 : 最近の肺門リンパ節結核 第1報 : 臨床像の変化と発症機序に関する考察. 結核 66 : 67-74, 1991.
 
4) 結核の統計 2020 (結核予防会編), 2020.
 
5) Im JG, et al : Mediastinal tuberculous lymphadenitis : CT manifestations. Radiology 164 : 115-119, 1987.
PubMed
6) Im JG, et al : Computed tomography of esophagomediastinal fistula in tuberculous mediastinal lymphadenitis. J Comput Assist Tomogr 14 : 89-92, 1990.
PubMed
7) Henkle E, et al : Surveillance of Extrapulmonary Nontuberculous Mycobacteria Infections, Oregon, USA, 2007-2012. Emerg Infect Dis 23 : 1627-1630, 2017.
PubMed
8) Haverkamp MH, et al : Nontuberculous mycobacterial infection in children : a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis 39 : 450-456, 2004.
PubMed
9) Doffinger R, et al : Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 38 : e10-14, 2004.
 
10) 磯野泰輔, ほか : 縦隔リンパ節転移との鑑別に経食道的気管支鏡下穿刺吸引生検法が有用であった縦隔リンパ節炎の1例. 気管支学 41 : 446-450, 2019.
Medical*Online
11) Roy D, et al : Benign superior vena cava syndrome due to suppurative mediastinal lymphadenitis : anterior mediastinoscopic management. Mayo Clin Proc 73 : 1185-1187, 1998.
PubMed
12) Norskov-Lauritsen N : Classification, identification, and clinical significance of Haemophilus and Aggregatibacter species with host specificity for humans. Clin Microbiol Rev 27 : 214-240, 2014.
PubMed
13) 小谷内敬史, ほか : 超音波気管支鏡ガイド下針生検 (EBUS-TBNA) により診断した縦隔リンパ節炎を伴う播種性クリプトコッカス症の1例. 気管支学 40 : 63-67, 2018.
Medical*Online
14) 渡辺哲, 亀井克彦 : 注意しなければいけない真菌・原虫感染症 コクシジオイデス症, ヒストプラズマ症, マルネッフェイ型ペニシリウム症. 臨床と微生物 47 : 275-279, 2020.
 
15) Wheat LJ, et al : Clinical practice guidelines for the management of patients with histoplasmosis : 2007 update by the infectious diseases society of America. Clin Infect Dis 45 : 807-825, 2007.
 
16) Nin CS, et al : Manifestations of infection by the novel influenza A (H1N1) virus at chest computed tomography. Radiol. Bras 42 : 343-348, 2009.
 
17) Salehi S, et al : Coronavirus disease 2019 (COVID-19) : a systematic review of imaging findings in 919 patients. AJR Am J Roentgenol 215 : 87-93, 2020.
PubMed
18) Valette X, et al : Mediastinal lymphadenopathy in patients with severe COVID-19. Lancet Infect Dis 20 : 1230, 2020.
PubMed
19) Goo JM, et al : Pulmonary tuberculoma evaluated by means of FDG PET : findings in 10 cases. Radiology 216 : 117-121, 2000.
PubMed
20) Navani N, et al : Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy : a multicentre study. Thorax 66 : 889-893, 2011.
PubMed
21) 御手洗聡 : 非結核性抗酸菌の微生物学的検査のup-to-date. 呼吸器内科 38 : 403-408, 2020.
 
P.291 掲載の参考文献
1) Kushner BH, et al : Neuroblastoma in adolescents and adults : the Memorial Sloan-Kettering experience. Med Pediatr Oncol 41 : 508-515, 2003.
PubMed
2) 岩井俊, ほか : 成人で発見された前縦隔神経芽腫の1切除例. 日本呼吸器外科学会雑誌 32 : 654-658, 2018.
 
3) 椙村彩, ほか : SIADHを合併した前縦隔神経芽腫の一切除例. 日本呼吸器外科学会雑誌 32 : 482-486, 2018.
 
4) Ogawa F, et al : Thymic neuroblastoma with the syndrome of inappropriate secretion of antidiuretic hormone. Interact Cardiovasc Thorac Surg 9 : 903-905, 2009.
PubMed
5) Pellegrino M, et al : Neuroblastoma in the Elderly and SIADH : Case Report and Review of the Literature. Case Rep Med 2012 : 952645, 2012.
PubMed
6) Wiesel O, et al : Ataxia induced by a thymic neuroblastoma in the elderly patient. World J Surg Oncol 13 : 178, 2015.
PubMed
7) Ueda Y, et al : Thymic Neuroblastoma within a Thymic Cyst in an Adult. Case Rep Oncol 5 : 459-463, 2012.
 
8) Brodeur GM, Maris JM : Neuroblastoma. In : Principles and Practice of Pediatric Oncology, 5th ed (ed by Pizzo PA, Poplack DG), p933-970, Lippincott Williams & Wilkins, Philadelphia, 2006.
 
9) Argani P, et al : Thymic neuroblastoma in adults : report of three cases with special emphasis on its association with the syndrome of inappropriate secretion of antidiuretic hormone. Am J Clin Pathol 108 : 537-543, 1997.
PubMed
10) Berthold F, Simon T : Clinical presentation. In : Neuroblastoma (ed by Cheung N-KV, Cohn SL), p63-85, Springer, Berlin, 2005.
 
11) Garaventa A, et al : Localized unresectable neuroblastoma : results of treatment based on clinical prognostic factors. Ann Oncol 13 : 956-964, 2002.
PubMed
12) 熊谷昌明 : 神経芽腫 ; 縦隔疾患. 縦隔腫瘍. 別冊日本臨牀新領域別症候群シリーズ No. 10 呼吸器症候群 (第2版) III, p525-527, 日本臨牀社, 2009.
 
13) Cohn SL, et al : The International Neuroblastoma Risk Group (INRG) classification system : an INRG Task Force report. J Clin Oncol 27 : 289-297, 2009.
PubMed
14) Monclair T, et al : The International Neuroblastoma Risk Group (INRG) staging system : an INRG Task Force report. J Clin Oncol 27 : 298-303, 2009.
PubMed
P.294 掲載の参考文献
1) Rossi GNI, et al : Idiopathic Mediastinal Fibrosis : a Systelnic Immune-Mediated Disorder. A Case Scries and a Review of the Literature. Clin Rev Allergy Immunol 52 : 446-459, 2017.
 
2) Rossi SE, et al : Fibrosing mediastinitis. Radiographics 21 : 737-757, 2001.
PubMed
3) 正岡昭, ほか : 縦隔外科全国集計. 日本胸部外科学会雑誌 19 : 1289-1300, 1971.
Medical*Online
4) Lull GF Jr, Winn DF Jr : Chronic fibrous mediastinitis due to Histoplasma capsulatum (histoplasmal mediastinitis). Report of three cases with different presenting symptoms. Radiology 73 : 367-373, 1959.
PubMed
5) Wightman SC, et al : An unusual case of Aspergillus fibrosing mediastinitis. Ann Thorac Surg 88 : 1352-1354, 2009.
PubMed
6) Fijoiek J, et al : Fibrosing mediastinitis as an untypical complication of tuberculosis : case report. Pol Arch Med Wewn 119 : 752-755, 2009.
 
7) Worrell JA, et al : Computed tomography and the idiopathic form of proliferative fibrosing mediastinitis. J Thorac Imaging 22 : 235-240, 2007.
PubMed
8) Moura MC, et al : Thoracic Involvement in IgG4-Related Disease. Semin Respir Crit Care Med 41 : 202-213, 2020.
PubMed
9) Rajaram R, et al : Acute and Chronic Mediastinal Infections. In : Shields' General Thoracic Surgery, 8th ed, Vol 2 (ed by LoCicero J III, et al), p2060-2074, Wolters Kluwer, Philadelphia, 2018.
 
10) Peikert T, et al : Histopathologic overlap between Fibrosing mediastinitis and IgG4-related disease. Int J Rheumatol 2012 : 207056, 2012.
PubMed
11) Loyd JE, et al : Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) 67 : 295-310, 1988.
PubMed
12) Chazova I, et al : Venous and arterial changes in pulmonary veno-occlusive disease, mitral stenosis and fibrosing mediastinitis. Eur Respir J 15 : 116-122, 2000.
PubMed
13) Flieder DB, et al : Idiopathic fibroinflammatory (fibrosing/sclerosing) lesions of the mediastinum : a study of 30 cases with emphasis on morphologic heterogeneity. Mod Pathol 12 : 257-264, 1999.
PubMed
14) Williams SM, Jones ET : General case of the day. Allergic (or hypersensitivity) bronchopulmonary aspergillosis (ABPA). Radiographics 17 : 1597-1600, 1997.
PubMed
15) Rodriguez E, et al : Fibrosing mediastinitis : CT and MR findings. Clin Radiol 53 : 907-910, 1998.
 
16) Takalkar AM, et al : A Potential Role for F-18 FDG PET/CT in Evaluation and Management of Fibrosing Mediastinitis. Clin Nucl Med 32 : 703-706, 2007.
PubMed
17) Okamoto K, Ichinose M : Idiopathic fibrosing mediastinitis mimicking nodal metastasis from breast cancer. Asian Cardiovasc Thorac Ann 25 : 663-664, 2017.
PubMed
18) Peikert T, et al : Fibrosing mediastinitis : clinical presentation, therapeutic outcomes, and adaptive immune response. Medicine (Baltimore) 90 : 412-423, 2011.
PubMed
19) Bays S, et al : Fibrosing mediastinitis as a cause of superior vena cava syndrome. Eur J Cardiothorac Surg 26 : 453-455, 2004.
PubMed
20) Zhang C, et al : Rare fibrosing granulomatous mediastinitis of tuberculosis with involvement of the transverse sinus. J Thorac Cardiovasc Surg 133 : 836-837, 2007.
PubMed
21) 加藤剛, ほか : ステロイドが有効であった特発性線維性縦隔炎の1例. 日本呼吸器学会雑誌 49 : 822-826, 2011.
Medical*Online
22) 石橋直也, ほか : ステロイドが著効した線維性縦隔炎の2例. 日本呼吸器外科学会雑誌 26 : 609-614, 2012.
 
23) Doty DB, et al : Bypass of superior vena cava. Fifteen years' experience with spiral vein graft for obstruction of superior vena cava caused by benign disease. J Thorac Cardiovasc Surg 99 : 889-895 ; discussion 895-896, 1990.
 
24) Mole TM, et al : Sclerosing mediastinitis : a report on 18 cases. Thorax 50 : 280-283, 1995.
PubMed
25) Welby JP, et al : Evaluation of Outcomes Following Pulmonary Artery Stenting in Fibrosing Mediastinitis. Cardiovasc Intervent Radiol 44 : 384-391, 2021.
PubMed
P.299 掲載の参考文献
1) 呼吸器外科テキスト-外科専門医・呼吸器外科専門医をめざす人のために- (日本呼吸器外科学会, 呼吸器外科専門医合同委員会編), p348-350, 南江堂, 2016.
 
2) 呼吸器外科学 [改訂 3版] (正岡昭監, 藤井義敬編), p295-297, 南山堂, 2003.
 
3) 加賀基知三, ほか : 呼吸器領域 降下性壊死性縦隔炎. 胸部外科 64 : 752-757, 2011.
 
4) 瀧島常雅, 相馬一亥 : 急性縦隔炎. 日本気管食道科学会会報 44 : 378-384, 1993.
 
5) 菊池寛利, 竹内裕也 : 食道 (2) 食道の良性疾患, 7 特発性食道破裂. 日本消化器外科学会公式テキスト 消化器外科専門医の心得, p203-206, 2020.
 
6) Ridder GJ, et al : Descending necrotizing mediastinitis : contemporary trends in etiology, diagnosis, management, and outcome. Ann Surg 251 : 528-534, 2010.
PubMed
7) Endo S, et al : Guideline of surgical management based on diffusion of descending necrotizing mediastinitis. Jpn J Thorac Cardiovasc Surg 47 : 14-19, 1999.
PubMed
8) 野中誠. 門倉光隆 : 降下性壊死性縦隔炎 : 早期発見と適正な治療のために. 日本集中治療医学会雑誌 15 : 41-48, 2008.
 
9) Gardlund B, et al : Postoperative mediastinitis in cardiac surgery-microbiology and pathogenesis. Eur J Cardiothorac Surg 21 : 825-830, 2012.
 
10) Pilarczyk K, et al : Tracheostomy After Cardiac Surgery With Median Sternotomy and Risk of Deep Sternal Wound Infections : Is It a Matter of Timing? J Cardiothorac Vasc Anesth 29 : 1573-1581, 2015.
PubMed
11) 栗本典昭, ほか : EBUS-TBNA後に生じた縦隔炎 (縦隔リンパ節炎) の1例. 日本呼吸器学会雑誌 49 : 588-591, 2011.
Medical*Online
12) Corsten MJ, et al : Optimaltreatment of descending necrotising mediastinitis. Thorax 52 : 702-708, 1997.
 
13) 1章 胸骨骨髄炎・縦隔炎 : CQ13 局所陰圧閉鎖療法 (NPWT) は有効か? 形成外科診療ガイドライン 3 慢性創傷 (日本形成外科学会, ほか編), p16-17, 金原出版, 2015.
 
P.304 掲載の参考文献
1) Pastene B, et al : Mediastinitis in the intensive care unit patient : a narrative review. Clin Microbiol Infect 26 : 26-34, 2020.
PubMed
2) Sumi Y : Descending necrotizing mediastinitis : 5 years of published data in Japan. Acute Med Surg 2 : 1-12, 2015.
PubMed
3) Brunelli A, et al : Descending necrotizing mediastinitis. Surgical drainage and tracheostomy. Arch Otolaryngol Head Neck Surg 122 : 1326-1329, 1996.
PubMed
4) 野中誠, 門倉光隆 : 降下性壊死性縦隔炎 早期発見と適正な治療のために. 日本集中治療医学会雑誌 15 : 41-48, 2008.
 
5) Estrera AS, et al : Descending necrotizing mediastinitis. Surg Gynecol Obstet 157 : 545-552, 1983.
PubMed
6) Exarhos DN, et al : Acute mediastinitis : spectrum of computed tomography findings. Eur Radiol 15 : 1569-1574, 2005.
PubMed
7) 嶋津岳士, ほか : 降下性壊死性縦隔炎 最新の治療戦略. 日本集中治療医学会雑誌 15 : 1-4, 2008.
 
8) Endo S, et al : Guideline of surgical management based on diffusion of descending necrotizing mediastinitis. Jpn J Thorac Cardiovasc Surg 47 : 14-19, 1999.
PubMed
9) Hirai S, et al : Surgical treatment of virulent descending necrotizing mediastinitis. Ann Thorac Cardiovasc Surg 10 : 34-38, 2004.
PubMed
10) Son HS, et al : Management of descending necrotizing mediastinitis using minimally invasive video-assisted thoracoscopic surgery. Surg Laparosc Endosc Percutan Tech 16 : 379-382, 2006.
PubMed
11) Nakamori Y, et al : Conventional open surgery versus percutaneous catheter drainage in the treatment of cervical necrotizing fasciitis and descending necrotizing mediastinitis. AJR Am J Roentgenol 182 : 1443-1449, 2004.
PubMed
12) 石川和男, ほか : 救急画像診断と初期治療 縦隔炎 特発性食道破裂, 下降性壊死性縦隔炎. 外科治療 78 : 1084-1097, 1998.
 
13) Ichimura H, et al : Innominate artery rupture after transcervical drainage for descending necrotizing mediastinitis. Ann Thorac Surg 71 : 1028-1030, 2001.
PubMed
P.308 掲載の参考文献
1) Sahni S, et al : Spontaneous pneumomediastinum : time for consensus. N Am J Med Sci 5 : 460-464, 2013.
PubMed
2) Kouritas VK, et al : Pneumomediastinum. J Thorac Dis 7 : S44-49, 2015.
PubMed
3) Hamman L : Spontaneous mediastinal emphysema. Bull Johns Hopkins Hosp 64 : 1-21, 1939.
 
4) 阪本仁, ほか : 特発性縦隔気腫症例の臨床的検討. 日本呼吸器外科学会雑誌 23 : 918-923, 2009.
 
5) Banki F, et al : Pneumomediastinum : etiology and a guide to diagnosis and treatment. Am J Surg 206 : 1001-1006 : discussion 1006, 2013.
 
6) Okada M, et al : Diagnosis and treatment of patients with spontaneous pneumomediastinum. Respir Investig 52 : 36-40, 2014.
PubMed
7) Caceres M, et al : Secondary pneumomediastinum : a retrospective comparative analysis. Lung 187 : 341-346, 2009.
PubMed
8) Koullias GJ, et al : Current assessment and management of spontaneous pneumomediastinum : experience in 24 adult patients. Eur J Cardiothorac Surg 25 : 852-855, 2004.
PubMed
9) Yamaguchi K, et al : Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum. Clin Rheumatol 38 : 3443-3450, 2019.
PubMed
10) Bakhos CT, et al : Spontaneous pneumomediastinum : an extensive workup is not required. J Am Coll Surg 219 : 713-717, 2014.
 
11) Ebina M, et al : Management of spontaneous pneumomediastinum : Are hospitalization and prophylactic antibiotics needed? Am J Emerg Med 35 : 1150-1153, 2017.
PubMed
12) Macia I, et al : Spontaneous pneumomediastinum : 41 cases. Eur J Cardiothorac Surg 31 : 1110-1114, 2007.
PubMed
13) Al-Mufarrej F, et al : Spontaneous pneumomediastinum : diagnostic and therapeutic interventions. J Cardiothorac Surg 3 : 59, 2008.
PubMed
14) Freixinet J, et al : Spontaneous pneumomediastinum long-term follow-up. Respir Med 99 : 1160-1163, 2005.
PubMed
P.311 掲載の参考文献
1) 神尾多喜浩, ほか : 後縦隔に発生した髄外造血巣の1例. 診断病理 28 : 134-136, 2011.
Medical*Online
2) 神山隆一, ほか : 血液疾患と脾臓. 病理と臨床 6 : 1423-1431, 1988.
 
3) 荒能義彦, ほか : 後縦隔腫瘤を形成したExtramedullary hematopoiesisの一治験例. 日本呼吸器外科学会雑誌 4 : 576-581, 1990.
 
4) Xiros N, et al : Massive hemothorax due to intrathoracic extramedullary hematopoiesis in a patient with hereditary spherocytosis. Ann Hematol 80 : 38-40, 2001.
 
5) 樋口光徳, ほか : 両側後縦隔原発の髄外造血巣の1手術例. 日本呼吸器外科学会雑誌 33 : 413-419, 2019.
 
6) Ross P, Logan W : Roentgen findings in extramedullary hematopoiesis. Am J Roentgenol 106 : 604-613, 1969.
 
7) Gormsen HJ : Uber das Vorkommen von Hamatopoietischen Gewebe in der menschlichen Nebenniere. Virchows Arch Pathol Anat 310 : 369-387, 1943.
 
8) Qiu D, et al : Extramedullary hematopoiesis on 18F-FDG PET/CT in a patient with thalassemia and nasopharyngeal carcinoma : A case report and literature review. J Cancer Res Ther 11 : 1034, 2015.
 
9) Petit JJ, Estany C : Mediastinal extramedullary erythroPoiesis in hereditary spherocytosis. Clin Lab Haematol 9 : 327-332, 1987.
PubMed
10) Wosick WF, et al : Radionuclide bone marrow scanning and computerized tomography in the diagnosis of extramedullary hematopoiesis presenting as an intrathoracic paravertebral mass. Clin Nucl Med 9 : 419, 1984.
PubMed
11) 牧内明子, ほか : 両側後縦隔髄外造血巣の1例. 日本呼吸器外科学会雑誌 14 : 698-702, 2000.
 
12) Santini M, et al : Intrathoracic extramedullary haematopoiesis manifested as a neoplastic lesion within anterior mediastinum. Ann Thorac Surg 88 : 2001-2004, 2009.
PubMed
13) 春田磨美, ほか : サラセミアに合併した後縦隔髄外造血巣の1例. 日本臨床細胞学会雑誌 38 : 462-466, 1999.
 
14) Elbers H, et al : Tumor-simulating thoracic extramedullary hematopoiesis. Ann Thorac Surg 30 : 584-587, 1980.
PubMed
15) 櫻庭幹, ほか : 胸腔鏡下に診断した胸腔内髄外造血巣. 胸部外科 67 : 319-322, 2014.
 
16) 橋本昌樹, ほか : 両側後縦隔に発生した髄外造血巣の1切除例. 日本呼吸器外科学会雑誌 27 : 754-758, 2013.
 
P.315 掲載の参考文献
1) Rojas CA, Restrepo CS : Mediastinal hematomas : aortic injury and beyond. J Comput Assist Tomogr 33 : 218-224, 2009.
PubMed
2) Melo AS, et al : [Traumatic chest lesions. Computed tomography findings]. Rev Port Pneumol 10 : 393-403, 2004.
PubMed
3) Wong H, et al : Periaortic hematoma at diaphragmatic crura at helical CT : sign of blunt aortic injury in patients with mediastinal hematoma. Radiology 231 : 185-189, 2004.
PubMed
4) Creasy JD, et al : Overview of traumatic injury of the thoracic aorta. Radiographics 17 : 27-45, 1997.
PubMed
5) Fisher RG, et al : Diagnosis of injuries of the aorta and brachiocephalic arteries caused by blunt chest trauma : CT vs aortography. AJR Am J Roentgenol 162 : 1047-1052, 1994.
PubMed
6) 前田敦雄. ほか : 胸骨圧迫が原因による著明な縦隔血腫から閉塞性ショックを来した1例. 日本救急医学会雑誌 29 : 224-229, 2018.
 
7) 玉井文洋, ほか : 縦隔血腫にて発症した特発性食道破裂の1例. 日本臨床外科学会雑誌 65 : 2894-2898, 2004.
 
8) Siefkin AD, et al : Unsuspected mediastinal hematoma diagnosed by computed tomography. J Comput Tomogr 8 : 211-214, 1984.
PubMed
9) Mikubo M, et al : Spontaneous non-traumatic mediastinal hematoma associated with oral anticoagulant therapy : A case report and literature review. Int J Surg Case Rep 39 : 221-224, 2017.
PubMed
10) Nitta M, et al : Pulmonary artery hypoplasia associated with posterior mediastinal hematoma accompanied by a ruptured pseudoaneurysm of the esophageal branch of the left gastric artery. Gen Thorac Cardiovasc Surg 65 : 425-428, 2017.
PubMed
P.319 掲載の参考文献
1) Derbes VJ, Mitchell RE Jr : Hermann Boerhaave's Atrocis, nec descripti prius, morbi historia, the first translation of the classic case report of rupture of the esophagus, with annotations. Bull Med Libr Assoc 43 : 217-240, 1955.
PubMed
2) 小島光暁, ほか : 特発性食道破裂14例の検討-治療成績と術式の工夫-. 日本腹部救急医学会雑誌 35 : 47-53, 2015.
 
3) 疋田茂樹, ほか : 食道破裂14例の検討. 日本腹部救急医学会雑誌 35 : 67-72, 2015.
 
4) 片岡祐一, ほか : 特発性食道破裂の治療に関する臨床的検討. 日本腹部救急医学会雑誌 35 : 73-77, 2015.
 
5) 千野修, ほか : 特発性食道破裂の治療成績と治療戦略. 日本腹部救急医学会雑誌 35 : 831-840, 2015.
 
6) Sohda M, et al : Clinical features of idiopathic esophageal perforation compared with typical post-emetic type : a newly proposed subtype in Boerhaave's syndrome. Esophagus 18 : 663-668, 2021.
PubMed
7) 酒井真, ほか : 特発性食道破裂. 臨床外科 71 (11増) : 215-219, 2016.
 
8) Kuwano H, et al : Pathophysiology of Vomiting and Esophageal Perforation in Boerhaave's Syndrome. Dig Dis Sci 65 : 3253-3259, 2020.
PubMed
9) 本城裕章, ほか : 手術療法を施行した食道穿孔および特発性食道破裂症例の検討. 日本腹部救急医学会雑誌 35 : 29-34, 2015.
 
10) Cameron JL, et al : Selective nonoperative management of contained intrathoracic esophageal disruptions. Ann Thorac Surg 27 : 404-408, 1979.
PubMed
11) Sealy WC : Rupture of the esophagus. Am J Surg 105 : 505-510, 1963.
PubMed
12) Gouge TH, et al : Experience with the Grillo pleural wrap procedure in 18 patients with perforation of the thoracic esophagus. Ann Surg 209 : 612-617 ; discussion 617-619, 1989.
 
13) Biancari F, et al : Current treatment and outcome of esophageal perforations in adults : systematic review and meta-analysis of 75 studies. World J Surg 37 : 1051-1059, 2013.
PubMed
14) Lazar G Jr, et al : A successful strategy for surgical treatment of Boerhaave's syndrome. Surg Endosc 25 : 3613-3619. 2011.
PubMed
P.323 掲載の参考文献
1) Marfan AB : Un cas de deformation congenitale des quatre membres, plue prononcee aux extremities, caracterisee par l'allongement des os avec un certain degre d'amincissement. Bul Sco Chir Paris 13 : 220-225, 1896.
 
2) Dietz HC, et al : Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352 : 337-339, 1991.
PubMed
3) Loeys BL, et al : The revised Ghent nosology for the Marfan syndrome. J Med Genet 47 : 476-485, 2010.
PubMed
4) Shprintzen-Goldberg syndrome, NORD (national Organization of Rare Disease). [https://rarediseases.org/rare-diseases/shprintzen-goldberg-syndrome]
 
5) MacCarrick G, et al : Loeys-Dietz syndrome : a primer for diagnosis and management. Genet Med 16 : 576-587, 2014.
PubMed
6) Ehlers Danlos syndrome, NORD (national Organization of Rare Disease). [https://rarediseases.org/rare-diseases/ehlers-danlos-syndrome]
 
7) 栗原正利, 山中澄隆 : 呼吸器外科医の立場から. 2017版 マルファン症候群ガイドブック [第3版] (沼部博直監), p120-135, マルファンネットワークジャパン, 2017.
 
8) Hall JR, et al : Pneumothorax in the Marfan syndrome : prevalence and therapy. Ann Thorac Surg 37 : 500-504, 1984.
PubMed
9) Kurihara M, et al : Latest treatments for spontaneous pneumothorax. Gen Thorac Cardiovasc Surg 58 : 113-119, 2010.
PubMed
10) Nuss D : Recent experiences with minimally invasive pectus excavatum repair "Nuss procedure". Jpn J Thorac Cardiovasc Surg 53 : 338-344, 2005.
PubMed
11) 国際マルファン症候群団体連合. [http://www.marfanworld.org]
 
12) Gene Review Japan [日本語版] (マルファン症候群). [http//grj.umin.jp/grj/marfan.htm]
 
13) 日本マルファン協会. [http://www.marfan.jp]
 
14) マルファンネットワークジャパン. [http://www.marfan.gr.jp]
 
P.327 掲載の参考文献
1) Poland A : Deficiency of the pectoral muscles. Guys Hosp Rep 6 : 191-193, 1841.
 
2) Charlier P, et al : Poland syndrome before Alfred Poland : the oldest medical description (Paris, France, 1803). Surg Radiol Anat 41 : 1117-1118, 2019.
 
3) Lallemand LM : Absence de trois cotes simulant un enfoncement accidentel. Ephemerides Medicales de Montpelier 1 : 144-147, 1826.
 
4) Froriep R : Beobachtungeines Falles von Mangel der Brustdruse. Notizen aus dem Gebiete der Natur und Heilkinde 10 : 9-14, 1839.
 
5) Clarkson P : Poland's syndactyly. Guys Hosp Rep 111 : 335-346, 1962.
PubMed
6) Al-Qattan MM : Classification of hand anomalies in Poland's syndrome. Br J Plast Surg 54 : 132-136, 2001.
PubMed
7) Cingel V, et al : Poland syndrome : from embryological basis to plastic surgery. Surg Radiol Anat 35 : 639-646, 2013.
PubMed
8) Baban A. et al : Poland syndrome with bilateral features : case description with review of the literature. Am J Med Genet A 149A 1597-1602, 2009.
PubMed
9) Bamforth JS, et al : Poland anomaly with a limb body wall disruption defect : case report and review. Am J Med Genet 43 : 780-784, 1992.
PubMed
10) Darian VB, et al : Familial Poland's syndrome. Ann Plast Surg 23 : 531-537, 1989.
PubMed
11) Fraser FC, et al : Pectoralis major defect and Poland sequence in second cousins : extension of the Poland sequence spectrum. Am J Med Genet 33 : 468-470, 1989.
PubMed
12) Bavinck JNB, Weaver DD : Subclavian artery supply disruption sequence : hypothesis of a vascular etiology for Poland, Klippel-Feil, and Mobius anomalies. Am J Med Genet 23 : 903-918, 1986.
 
13) Merlob P, et al : Real-time echo-Doppler Duplex Scanner in the evaluation of patients with Poland sequence. Eur J Obstet Gynecol Reprod Biol 32 : 103-108, 1989.
PubMed
14) Ferraro GA, et al : Poland syndrome : description of an atypical variant. Aesthetic Plast Surg 29 : 32-33, 2005.
PubMed
15) Atasoy HI, et al : A unique case of right-sided Poland syndrome with true dextrocardia and total situs inversus. Eur J Pediatr 172 : 269-272, 2013.
PubMed
16) Van Allen MI : Fetal vascular disruptions : mechanisms and some resulting birth defects. Pediatr Ann 10 : 219-233, 1981.
PubMed
17) Congdon ED : Transformation of the aortic-arch system during the development of the human embryo. Carnegie Institution Washington Contributions to Embryology 14 : 47-113, 1922.
 
18) Puvabanditsin S, et al : Poland-Mobius syndrome and cocaine abuse : a relook at vascular etiology. Pediatr Neurol 32 : 285-287, 2005.
PubMed
19) Hashim EAA, et al : A narrative review of Poland's syndrome : theories of its genesis, evolution and its diagnosis and treatment. Transl Pediatr 10 : 1008-1019, 2021.
PubMed
20) 井上善博, ほか : 先天性胸筋欠損症に併発した乳癌の1例. 日本臨床外科学会雑誌 69 : 2799-2803, 2008.
 
21) 樋熊有子, ほか : Poland症候群におけるtissue expanderを用いた乳房形成の1例. 形成外科 48 : 655-659, 2005.
 
22) 武石明精, ほか : 先天性大胸筋欠損症の乳房再建術. 日本形成外科学会会誌 24 : 403-411, 2004.
 
P.331 掲載の参考文献
1) Rawlings MS : The "straight back" syndrome, a new cause of pseudoheart disease. Am J Cardiol 5 : 333-338, 1960.
PubMed
2) Udoshi MB, et al : Incidence of mitral valve prolapse in subjects with thoracic skeletal abnormalities-a prospective study. Am Heart J 97 : 303-311, 1979.
PubMed
3) Davies MK, et al : The straight back syndrome. Q J Med 49 : 443-460, 1980.
PubMed
4) Salomon J, et al : Thoracic skeletal abnormalities in idiopathic mitral valve prolapse. Am J Cardiol 36 : 32-36, 1975.
PubMed
5) Bon Tempo CP, et al : Radiographic appearance of the thorax in systolic click-late systolic murmur syndrome. Am J Cardiol 36 : 27-31, 1975.
PubMed
6) Movahed A, et al : Association between myxomatous mitral valve disease and skeletal back abnormalities. J Heart Valve Dis 26 : 564-568, 2017.
PubMed
7) Raggi P, et al : Is mitral valve prolapse due to cardiac entrapment in the chest Cavity? A CT view. Chest 117 : 636-642, 2000.
 
8) De Leon AC, et al : The straight back syndrome : clinical cardiovascular manifestations. Circulation 32 : 193-203, 1965.
 
9) Ansari A : The "straight back" syndrome : current perspective more often associated with valvular heart disease than pseudoheart disease : a prospective clinical, electrocardiographic, roentgenographic, and echocardiographic study of 50 patients. Clin Cardiol 8 : 290-305, 1985.
PubMed
10) Gould KG, et al : Pulmonary function and work capacity in the absence of physiologic dorsal kyphosis of the spine. Dis Chest 55 : 405-410, 1969.
PubMed
11) Wright CD : Straight back syndrome. Thorac Surg Clin 27 : 133-137, 2017.
PubMed
P.336 掲載の参考文献
1) Baldes N, Schirren J : Primary and Secondary Tumors of the Diaphragm. Thorac Cardiovasc Surg 64 : 641-646, 2016.
PubMed
2) Kandemirli SG, et al : Cross-sectional imaging and laparoscopic findings of diaphragmatic mesothelial cysts. Clin Radiol 75 : 239e9-239e14, 2020.
PubMed
3) Taira N, et al : Mucoepidermoid Carcinoma of Arising from a Bronchogenic Cyst of the Diaphragm. Ann Thorac Cardiovasc Surg 24 : 247-250, 2018.
PubMed
4) Baram A, et al : Diaphragmatic lipoma ; A benign condition necessitating an aggressive management. Int J Surg Case Rep 65 : 57-60, 2019.
PubMed
5) Melis M, et al : Primary Rhabdomyosarcoma of the Diaphragm. Case Report and Review of the Literature. J Gastrointest Surg 17 : 799-804, 2013.
PubMed
6) Zhang H, et al : Primary fibrosarcoma of the diaphragm with pleural effusion. Clin Respir J 4 : 127-128, 2010.
PubMed
7) Ravi V, Patel S : Vascular sarcomas. Curr Oncol Rep 15 : 347-355, 2013.
 
8) 軟部腫瘍診療ガイドライン 2020 [改訂第3版] (日本整形外科学会診療ガイドライン委員会. 軟部腫瘍診療ガイドライン策定委員会編), 南江堂, 2020.
 
9) Zhang Y, et al : Primary yolk sac tumor in diaphragm. Pediatr Surg Int 28 : 1157-1160, 2012.
PubMed
10) Okada S, et al : Isolated Diaphragmatic Metastasis Originating From Early Endometrial Cancer. Ann Thorac Surg 110 : e27-e29, 2020.
PubMed
11) 冨永信太, ほか : 術後2年目に横隔膜転移を切除した上行結腸癌の1例. 和歌山医学 70 : 117-120, 2019.
Medical*Online
12) Mactier RA, et al : Role of peritoneal cavity lymphatic absorption in peritoneal dialysis. Kidney Int 32 : 165-172, 1987.
PubMed
13) 横山裕之, 星野澄人 : 腹腔内に発生した横隔膜原発巨大横紋筋肉腫の1切除例. 手術 54 : 1653-1656, 2000.
 
14) 稲岡健一, ほか : FDG-PETで高集積を示した原発性横隔膜神経鞘腫の1例. 臨床外科 70 : 1145-1150, 2015.
 
15) Seki S, et al : Diffusion-weighted MR imaging vs. multi-detector row CT : Direct comparison of capability for assessment of management needs for anterior mediastinal solitary tumors. Eur J Radiol 83 : 835-842, 2014.
PubMed
P.341 掲載の参考文献
1) Langham MR, et al : Congenital diaphragmatic hernia. Epidemiology and outcome. Clin Perinatol 23 : 671-688, 1996.
PubMed
2) Toda M, et al : Right-sided Bochdalek hernia containing retroperitoneal fat in the elderly : report of a case. Surg Case Rep 5 : 81, 2019.
PubMed
3) Attar I, et al : [Understanding and guidelines for the management of antenatal diagnosis of diaphragmatic hernia : prognostic factors]. Pan Afr Med J 39 : 9, 2021.
PubMed
4) 芦川和広, ほか : 胸腔内に小腸穿孔を来した成人Bochdalek孔ヘルニアの1例. 日本消化器外科学会雑誌 43 : 1054-1058, 2010.
 
5) Mous DS, et al : Pulmonary vascular development in congenital diaphragmatic hernia. Eur Respir Rev 27 : 170104, 2018.
PubMed
6) Chandrasekharan PK, et al : Congenital Diaphragmatic hernia-a review. Matern Health Neonatol Perinatol 3 : 6, 2017.
PubMed
7) 山口晃司, ほか : 成人Bochdalek孔ヘルニアに対し胸腔鏡-腹腔鏡併用手術を施行した1例. 日本臨床外科学会雑誌 72 : 49-53, 2011.
 
8) Hyun JJ, Bak YT : Clinical significance of hiatal hernia. Gut Liver 5 : 267-277, 2011.
PubMed
9) 草野元康, ほか : 日本人の食道裂孔ヘルニアの頻度. 日本消化器内視鏡学会雑誌 47 : 962-973, 2005.
 
10) 足立経一, ほか : 食道裂孔ヘルニアの正確な診断. 日本消化器内視鏡学会雑誌 49 : 2540-2549, 2007.
 
11) Karush J, Sarkaria IS : Robotic-Assisted Giant Paraesophageal Hernia Repair and Nissen Fundoplication. Oper Tech Thorac Cardiovasc Surg 18 : 204-214, 2013.
 
12) Oppelt PU, et al : Morgagni-Larrey diaphragmatic hernia repair in adult patients : a retrospective single-center experience. Hernia 25 : 479-489, 2021.
PubMed
13) Lu J, et al : Delayed traumatic diaphragmatic hernia : A case-series report and literature review. Medicine (Baltimore) 95 : e4362, 2016.
 
14) Carter BN, et al : Traumatic diaphragmatic hernia. Am J Roentgenol Radium Ther 65 : 56-72, 1951.
PubMed
15) McGivern MR, et al : Epidemiology of congenital diaphragmatic hernia in Europe : a register-based study. Arch Dis Child Fetal Neonatal Ed 100 : F137-144, 2015.
PubMed
P.346 掲載の参考文献
1) Wayne ER, et al : Eventration of the diaphragm. J Pediatr Surg 9 : 643-651, 1974.
PubMed
2) 佐藤達夫 : 胸部と腹部を仕切る横隔膜. 横隔膜のつくりと形, 横隔膜の神経-横隔神経, 人体スペシャル 胸部の地図帳, p82-87, p90-91, 講談社, 2008.
 
3) McCool FD, Tzelepis GE : Dysfunction of the diaphragm. N Engl J Med 366 : 932-942, 2012.
PubMed
4) Chihara K, et al : Reconstruction of Phrenic Nerve (Best Poster Award), the 11th Congress of the Asian Pacific Society of Respirology (APSR), p2-91, 2006. 11. 21 (Kyoto).
 
5) Bolton CF : AAEM minimonograph #40 : clinical neurophysiology of the respiratory system. Muscle Nerve 16 : 809-818, 1993.
PubMed
6) 武田伸一, ほか : 横隔神経麻痺に対する横隔膜縫縮術が横隔膜機能に及ぼす影響についての研究. 日本外科学会雑誌 92 : 1367-1370, 1991.
 
7) Schwartz MZ, Filler RM : Plication of the diaphragm for symptomatic phrenic nerve paralysis. J Pediatr Surg 13 : 259-263, 1978.
PubMed
8) Mouroux J, et al : Surgical treatment of diaphragmatic eventration using video-assisted thoracic surgery : a prospective study. Ann Thorac Surg 79 : 308-312, 2005.
PubMed
9) Mackinnon SE, Dellon AL : Classification of Nerve Injuries as the Basis for Treatment. Nerve Repair and Nerve Grafting. In : Surgery of the Peripheral Nerve, p35-63, Thieme Medical Publishers, New York, 1988.
 
10) 長野昭 : 神経移行術による麻痺肢の機能再建. 神経研究の進歩 40 : 755-762, 1996.
 
11) 川島重明, ほか : 横隔 (膜) 神経縫合の1例. 整形外科 36 : 77-79, 1985.
 
12) Merav AD, et al : Successful repair of a transected phrenic nerve with restoration of diaphragmatic function. Chest 84 : 642-644, 1983.
PubMed
13) Schoeller T, et al : Successful immediate phrenic nerve reconstruction during mediastinal tumor resection. J Thorac Cardiovasc Surg 122 : 1235-1237, 2001.
PubMed
14) Brouillette RT, et al : Successful reinnervation of the diaphragm after phrenic nerve transection. J Pediatr Surg 21 : 63-65, 1986.
PubMed
15) 小林淳, 住友亮太 : RS 03-01 横隔膜弛緩症の治療 横隔膜運動と神経伝導の回復, 日本呼吸器外科学会雑誌 26 (Suppl) : 55, 2012.
 
P.350 掲載の参考文献
1) Queisser-Luft A, et al : Malformations in newborn : results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998). Arch Gynecol Obstet 266 : 163-167, 2002.
PubMed
2) Smith S, et al : Embryology, Anatomy, and Variants of the Kidneys and Genitourinary Tract. In : Caffey's Pediatric Diagnostic Imaging, 13th ed (ed by Coley BD, et al), p1065-1075. e1062, Elsevier, Philadelphia, 2018.
 
3) Limwongse C : Developmental syndromes and malformations of the urinary tract. In : Pediatric Nephrology, 7th ed (ed by Avner ED, et al), p135-178, Springer-Verlag, Berlin, 2016.
 
4) VanderBrink BA, et al : Anomalies of the Upper Urinary Tract. In : Campbell-Walsh-Wein Urology, 12th ed review (Partin AW, et al), p714-740, Elsevier, Philadelphia, 2020.
 
5) Pfister-Goedeke L, Brunier E : [Intrathoracic kidney in childhood with special reference to secondary renal transport in Bochdalek's hernia]. Helv Paediatr Acta 34 : 345-357, 1979.
PubMed
6) Campbell MF : Renal ectopy. J Urol 24 : 187-198, 1930.
 
7) Wolfromm MG : Situation du rein dans l'eventration diaphragmatique droite [In French]. Mem Acad Chirur 60 : 41-47, 1940.
 
8) Navaratnarajah A, et al : Bochdalek hernias associated with intrathoracic kidney : A case report and systematic review of outcomes including renal function. Clin Nephrol Case Stud 8 : 1-11, 2020,
 
9) Donat SM, Donat PE : Intrathoracic kidney : a case report with a review of the world literature. J Urol 140 : 131-133, 1988.
 
10) Al-Saqladi AW, Akares SA : Intrathoracic kidney in a child with literature review. Saudi J Kidney Dis Transpl 26 : 349-354, 2015.
 
11) 泌尿生殖器系. ムーア人体発生学 [原著第6版] (瀬口春道監訳), p319-366, 医歯薬出版, 2001.
 
12) Murphy JJ, et al : The intrathoracic kidney : should we fix it? J Pediatr Surg 47 : 970-973, 2012.
PubMed
13) Ilgi M, et al : A rare malformation of urinary system : Right ectopic thoracic kidney. Urol Ann 9 : 299-300, 2017.
PubMed
14) Masturzo B, et al : Prenatal diagnosis of an ectopic intrathoracic kidney in right-sided congenital diaphragmatic hernia using color Doppler ultrasonography. Ultrasound Obstet Gynecol 18 : 173-174, 2001.
PubMed
15) Haller JO, et al : Thoracic Kidney (Superior Ectopia). In : Caffey's Pediatric Diagnostic Imaging, 10th ed (ed by Kuhn JP), p1762-1763, Mosby, Philadelphia, 2004.
 
P.353 掲載の参考文献
1) Laurence KM : Congenital pulmonary lymphangiectasis. J Clin Pathol 12 : 62-69, 1959.
PubMed
2) Noonan JA, et al : Congenital pulmonary lymphangiectasis. Am J Dis Child 120 : 314-319, 1970.
PubMed
3) Esther CR Jr, Barker PM : Pulmonary lymphangiectasia. diagnosis and clinical Course. Pediatr Pulmonol 38 : 308-313, 2004.
PubMed
4) 永山善久 : 先天性肺リンパ管拡張症. 呼吸 31 : 448-452, 2012.
Medical*Online
5) Hislop A, Reid L : Intra-pulmonary arterial development during fetal life-branching pattern and structure. J Anat 113 : 35-48, 1972.
PubMed
6) Yamaki S, et al : Quantitative analysis of pulmonary vascular disease in total anomalous pulmonary venous connection in sixty infants. J Thorac Cardiovasc Surg 104 : 728-735, 1992.
PubMed
7) 藤田雄治, ほか : 先天性肺リンパ管拡張症3例の臨床的・病理学的検討. 日本小児科学会雑誌 123 : 978-985, 2019.
 
8) Yao LC, et al : Pulmonary lymphangiectasia resulting from vascular endothelial growth factor-C overexpression during a critical period. Circ Res 114 : 806-822, 2014.
PubMed
9) Stevenson DA, et al : Familial congenital non-immune hydrops, chylothorax, and pulmonary lymphangiectasia. Am J Med Genet A 140 : 368-372, 2006.
PubMed
10) Njolstad PR, et al : Familial non-immune hydrops fetalis and congenital pulmonary lymphangiectasia. Eur J Pediatr 157 : 498-501, 1998.
PubMed
11) Yuan SM : Congenital pulmonary lymphangiectasia. J Perinat Med 45 : 1023-1030, 2017.
PubMed
12) Nobre LF, et al : Congenital pulmonary lymphangiectasia : CT and pathologic findings. J Thorac Imaging 19 : 56-59, 2004.
 
13) Victoria T, Andronikou S : The fetal MR appearance of 'nutmeg lung' : findings in 8 cases linked to pulmonary lymphangiectasia. Pediatr Radiol 44 : 1237-1242, 2014.
PubMed
14) 横田千恵, ほか : 胎児超音波・MRI検査により先天性肺リンパ管拡張症と診断した1例. 日本周産期・新生児医学会雑誌 53 : 202-205, 2017.
Medical*Online
15) Barrera CA, et al : Prognostic value of the nutmeg lung pattern/lymphangiectasia on fetal magnetic resonance imaging. Pediatr Radiol 51 : 1809-1817, 2021.
PubMed
16) Yalcin S, et al : Childhood pneumonectomies : two decades' experience of a referral center. Eur J Pediatr Surg 23 : 115-120, 2013.
PubMed
17) Reiterer F, et al : Severe primary pulmonary lymphangiectasis in a premature infant : management and follow up to early childhood. Pediatr Int 57 : 166-169, 2015.
 
18) Reiterer F, et al : Congenital pulmonary lymphangiectasis. Paediatr Respir Rev 15 : 275-280, 2014.
PubMed
19) Hwang JH, et al : Pneumonectomy case in a newborn with congenital pulmonary lymphangiectasia. J Korean Med Sci 29 : 609-613, 2014.
 
20) Adair D, et al : Case Report : A Relatively Mild Presentation of Unilateral Congenital Pulmonary Lymphangiectasia. Front. Pediatr 9 : 657473, 2021.
PubMed
P.358 掲載の参考文献
1) Lesbo M, et al : Compromised cardiac function in exercising teenagers with pectus excavatum. Interact Cardiovasc Thorac Surg 13 : 377-380, 2011.
PubMed
2) Haller JA Jr, et al : Use of CT scans in selection of patients for pectus excavatum surgery : a preliminary report. J Pediatr Surg 22 : 904-906, 1987.
PubMed
3) Wang Q, et al : Changes in resting pulmonary function testing over time after the Nuss procedure : A systematic review and meta-analysis. J Pediatr Surg 53 : 2299-2306, 2018.
PubMed
4) Nuss D, et al : A 10-year review of a minimally invasive technique for the correction of pectus excavatum. J Pediatr Surg 33 : 545-552, 1998.
PubMed
5) Mao YZ, et al : Comparison of the Nuss versus Ravitch procedure for pectus excavatum repair : an updated meta-analysis. J Pediatr Surg 52 : 1545-1552, 2017.
PubMed
6) Ewais MM, et al : Outcomes in adult pectus excavatum patients undergoing Nuss repair. Patient Relat Outcome Meas 9 : 65-90, 2018.
PubMed
P.362 掲載の参考文献
1) 日本外傷データバンク報告 2020 (2019.1-2019.12). [https://www.jtcr-jatec.org/traumabank/dataroom/data/JTDB2020.pdf] (2021年10月閲覧)
 
2) 改訂第5版外傷初期診療ガイドライン JATEC (日本外傷学会, 日本救急医学会監, 日本外傷学会外傷初期診療ガイドライン改訂第5版編集委員会編), p75-90, へるす出版, 2016.
 
3) Perez-Alonso D, et al : Selective packing for uncontrollable traumatic thoracic wall bleeding preserving cardiopulmonary function. Am J Surg 214 : 413-415, 2017.
PubMed
4) O'Connor JV, et al : Damage-control thoracic surgery : Management and outcomes. J Trauma Acute Care Surg 77 : 660-665, 2014.
PubMed
5) 千葉直久, ほか : 肋骨骨折端による下行大動脈損傷が原因であった遅発性血胸の1手術例. 日本呼吸器外科学会雑誌 28 : 893-897, 2014.
 
6) Igai H, et al : Delayed massive hemothorax due to a diaphragmatic laceration caused by lower rib fractures. Gen Thorac Cardiovasc Surg 67 : 811-813, 2019.
PubMed
7) Marasco SF, et al : Prospective randomized controlled trial of operative rib fixation in traumatic flail chest. J Am Coll Surg 216 : 924-932, 2013.
PubMed
8) Cho HJ, et al : Traumatic pulmonary pseudocysts after blunt chest trauma : Prevalence, mechanisms of injury, and computed tomography findings. J Trauma Acute Care Surg 79 : 425-430, 2015.
PubMed
9) Igai H, et al : Delayed hepatothorax due to right-sided traumatic diaphragmatic rupture. Gen Thorac Cardiovasc Surg 55 : 434-436, 2007.
PubMed
10) Tagami T, et al : Thoracic aortic injury in Japan-nationwide retrospective cohort study. Circ J 79 : 55-60, 2015.
PubMed
11) 境雄大, ほか : 鈍的外傷後に診断された胸部下部食道破裂の1例. 日本消化器外科学会雑誌 41 : 481-486, 2008.
 

書評

最近チェックした商品履歴

Loading...